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Development of Vessels, Airways and Cartilage Rings: The role of T-box genes 
Ripla Arora 
 
Tbx4 and Tbx5 are two closely related genes that belong to the T-box family of transcription 
factor genes.  Loss of Tbx4 results in absence of chorio-allantoic fusion and a failure of 
formation of the primary vascular plexus of the allantois leading to embryonic death at E10.5.  
Using a candidate gene approach we identified a number of genes downstream of Tbx4 in the 
allantois including, extracellular matrix molecules Vcan, Has2, Itgα5; transcription factors Snai1 
and Twist, and signaling molecules Bmp2, Bmp7, Notch2, Jag1 and Wnt2.  In addition, we show 
that the canonical Wnt signaling pathway contributes to the vessel-forming potential of the 
allantois.  Ex vivo, the Tbx4 mutant phenotype can be rescued using agonists of the Wnt 
signaling pathway and an inhibitor of the canonical Wnt signaling pathway phenocopies the 
Tbx4 mutant phenotype in wildtype allantoises.  In vivo, Tbx4 and Wnt2 double heterozygous 
placentas show decreased vasculature suggesting interactions between Tbx4 and the canonical 
Wnt signaling pathway in the process of allantois-derived blood vessel formation. 
Both Tbx4 and Tbx5 are expressed throughout the mesenchyme of the developing respiratory 
system.  Normal development of the respiratory system is essential for survival and is regulated 
by multiple genes and signaling pathways.   Although many genes are known to be required in 
the epithelium, only Fgfs have been well studied in the mesenchyme.  We investigated the roles 
of Tbx4 and Tbx5 in lung and trachea development using conditional mutant alleles and two 
different Cre recombinase transgenic lines.  Loss of Tbx5 leads to a unilateral loss of lung bud 




and Tbx5 show severely reduced lung branching at mid-gestation.  Concordant with this defect, 
the expression of mesenchymal markers Wnt2 and Fgf10, as well as Fgf10 target genes in the 
epithelium, Bmp4 and Spry2, is downregulated.  Lung branching undergoes arrest ex vivo when 
Tbx4 and Tbx5 are both completely lacking.  Lung-specific Tbx4 heterozygous;Tbx5 conditional 
null mice die soon after birth due to respiratory distress.  These pups have small lungs and show 
severe disruptions in tracheal-bronchial cartilage rings.  Sox9, a master regulator of cartilage 
formation, is expressed in the trachea but mesenchymal cells fail to condense and consequently 
do not develop cartilage normally at birth.  Tbx4;Tbx5 double heterozygous mutants show 
decreased lung branching and fewer tracheal cartilage rings, suggesting a genetic interaction.   
Finally, we show that Tbx4 and Tbx5 interact with Fgf10 during the process of lung growth and 
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T-box genes are a family of transcription factor genes, important for normal embryonic 
development in different organisms.  Tbx4 and Tbx5, the most closely related pair of T-box 
genes, show distinct and overlapping areas of expression during embryogenesis.  Here we 
explore the function of these genes in areas of unique expression, Tbx4 in the developing murine 
allantois, Tbx5 in the early foregut; and in areas of common expression, Tbx4 and Tbx5 in the 
developing lung and trachea.  Chapter 1 outlines the discovery of T-box genes, highlights the 
salient features of this family of genes as transcription factors, and their general role in 
development, in particular Tbx4 and Tbx5.  Upon targeted mutagenesis, loss of Tbx4 produces an 
allantois and hindlimb phenotype but the mechanisms by which Tbx4 acts in the allantois is not 
clear.  The second part of Chapter 1 introduces the murine allantois and provides an extensive 
review of literature described under the subheading “The murine allantois: a model system for 
the study of blood vessel formation”.  This section has been submitted as an invited review to the 
journal Blood.  The final section in Chapter 1 introduces the respiratory system, an organ system 
that expresses both Tbx4 and Tbx5.  In Chapter 2, a battery of genes affected by loss of Tbx4 
expression in the allantois were discovered using a candidate gene approach.  Further, the role of 
canonical Wnt signaling was characterized downstream of Tbx4 in the development of the 
allantois and placental vasculature.  Although Tbx5 function has been extensively studied in the 
heart, neither Tbx4 nor Tbx5 function has been examined in the developing murine respiratory 
system.  Chapter 3 characterizes the expression pattern of Tbx4 and Tbx5 in the primordia of the 
respiratory system, the developing lung and developing trachea.  Subsequently, the function of 
both these genes and their interactions were analyzed in the specification of the lung/trachea 









                                                 
1





Chapter 1. Introduction to T-box genes, the murine allantois and the 
respiratory system  
1.1  T-Box Genes 
History 
A mutation in the Brachyury or T locus, first described in 1927, was one of the earliest 
recognized developmental genes in mice. Embryological defects caused by mutations at this 
locus cause embryonic death in homozygotes and defects in tail development in heterozygotes 
(hence the locus name Brachyury which means short tail, symbolized as T for tail). In 1990, the 
gene itself was cloned and found to be a novel transcription factor, and soon the existence of a 
family of T-related genes was demonstrated by the discovery of genes in both Drosophila and 
mice, with sequence homology to T. The conserved DNA binding domain that defined the family 
was named the T-box, giving the family its name. T-box genes have now been found in virtually 
all metazoan species as divergent as the roundworm, Caenorhabditis elegans, and Homo sapiens 
(Papaioannou, 2001). 
Defining features of the family 
The T-box family of genes encodes putative transcription factors. The defining feature of the 
family is a 180-190 amino acid long T-box domain, which has been shown to have DNA binding 
activity. This domain is conserved amongst all the T-box family members. DNA binding 
activity, along with the nuclear localization of the gene products, suggests that these proteins act 
as transcriptional regulators of other genes (Papaioannou, 2001; Naiche et al., 2005). T-box 
proteins have, in fact, been shown to act as both repressors and activators of transcription. For 





Chapman, 2005); on the other hand Tbx2 is known to repress heart chamber differentiation-
specific genes including Nppa, Cx40 and Cx43 (Christoffels et al., 2004; Harrelson and 
Papaioannou, 2006). 
T-box proteins can act as homodimers or heterodimers with different members of the 
family and can also interact with transcription factors of other families. The polypeptide encoded 
outside of the T-box region varies between different T-box genes and hence imparts specificity 
of function, for example, by promoting interactions with a different set of proteins or 
transcription factors. Tbx20 interacts with GATA5 but not the related transcription factor 
GATA4 (Stennard et al., 2003). LMP4 binds both of the most closely related vertebrate T-box 
proteins Tbx4 and Tbx5, but interacts with each via a different LIM domain repeat (Krause et al., 
2004). 
The DNA sequence which the T-box binds, the T-box binding element (TBE) or T-site, 
was first defined for Brachyury as the sequence with the highest affinity (Kispert and Herrmann, 
1993).  Brachyury binds this palindromic sequence as a dimer, with each monomer of Brachyury 
binding half of the sequence of the T-site (5’-AGGTGTGAAATT-3’). All the T-box proteins 
tested are capable of binding the T-half site as monomers. In addition to the T-half site, specific 
binding elements for other T-box genes have also been identified, which are similar but not 
identical to the T-half site. The binding specificity of the TBE provides another example of how 
the T-box genes are similar yet distinct in function (Naiche et al., 2005). 
Phylogenetic analysis 
Phylogenetic analysis of the T-box gene family reveals that this is an ancient gene family. Its 
initial expansion from a single progenitor sequence appears to have occurred at the outset of 





evolutionary lineages. Together with gene expression studies, phylogenetic comparisons also 
provide evidence for the existence of T-box gene subfamilies whose more recently duplicated 
members retain similar or overlapping patterns of gene expression, possibly correlated with 
conserved function. For example, the Tbx2 and Tbx3 genes are members of the ancient vertebrate 
Tbx2 subfamily that expanded prior to the divergence of bony fish and tetrapods. These two 
genes have expression patterns that are broadly similar, both within and between species, 
although temporal and spatial differences in expression may reflect divergence of function that 
could have occurred since the separation of the genes (Epstein et al., 2008). 
Phylogenetics also allows the identification of what are likely to be orthologs of the same 
gene in different species. Orthologs are defined as direct descendant from a single ancestral gene 
that was present in the genome of the common ancestor of the species under analysis, for 
example the Brachyury orthologs found in many species (Figure 1.1, T subfamily). Analysis of 
the T-box family tree can direct the search for new T-box genes by predicting the existence of 
orthologs in species where they have yet to be discovered, thus hastening gene discovery 
(Epstein et al., 2008). 
Role in development 
Although several T-box genes are known to be expressed in adult tissues, their widespread 
expression in embryonic tissues, particularly in areas of inductive tissue interactions emphasizes 
a major role for these genes in development. The best way to study T-box gene function is by 
finding or creating loss of function mutations in a gene in order to study the effects of its 
disruption. In addition to the well studied Brachyury mutations in the mouse which affect 
development of posterior structures including the tail (Yanagisawa et al., 1981), mutant alleles of 





ortholog, no tail, also show effects on the development of posterior structures (Schulte-Merker et 
al., 1994), illustrating comparable functions of orthologs in widely divergent species.   
Tbx4 and Tbx5: expression and function 
Tbx4 and Tbx5 belong to the Tbx2 subfamily and are the most closely related T-box genes with 
94% homology in their T-box amino acid sequence (Epstein et al., 2008).  In the developing 
chick embryo Tbx4 expression has been detected in the hind limb, lung bud/trachea, genital 
papilla and the notochord (Gibson-Brown et al., 1998).  In the developing mouse embryo Tbx4 is 
expressed in the allantois, hindlimb, genital papilla, lung mesenchyme, trachea mesenchyme, 
mandible mesenchyme (Chapman et al., 1996), a small domain in the proximal core of the 
forelimb (Naiche et al., 2011) and both male and female germ cells (Douglas et al., 2011).  In 
zebrafish Tbx4 expression has been reported in the developing and adult pelvic fin (Tamura et 
al., 1999) which is the homolog for the hindlimb in the chick and the mouse.  Tbx5 expression in 
the chick has been identified in the heart atrium, ventricle, genital papilla, forelimb, lung 
bud/trachea, notochord and optic vesicle (Gibson-Brown et al., 1998).  In the developing mouse 
embryo Tbx5 expression has been detected in the forelimb, heart atrium and ventricle, genital 
papilla, lung mesenchyme, trachea mesenchyme, mandible mesenchyme and neural retina of the 
optic vesicle (Chapman et al., 1996).  In the zebrafish, Tbx5 expression has been detected in the 
retina, the pectoral fin buds, which are the homologues for forelimbs (Tamura et al., 1999) and 
the developing heart atrium and sinus venosus (Begemann and Ingham, 2000). 
In the chick Tbx4 function has been studied in the developing lung and trachea. Ectopic 
expression of Tbx4 on the border of trachea and esophagus causes tracheoesophageal fistula. 
Furthermore, ectopic Tbx4 expression induces Nkx2.1 expression, Fgf10 expression and lung bud 





respiratory primordia on its own (Sakiyama et al., 2003).  Homozygous loss of Tbx4 in mice is 
embryonic lethal due to lack of chorio-allantoic fusion and absence of placenta formation.  
Additionally, the Tbx4 null mutant allantois shows apoptosis and a failure of differentiated 
endothelial cells (ECs) to form umbilical vessels.  The hind limb buds in Tbx4 null mutant 
embryos appear but then fail to outgrow and lose Fgf10 expression (Naiche and Papaioannou, 
2003). Later in development, once hindlimb outgrowth has successfully occurred, Tbx4 is 
important for formation of core tissue (Naiche and Papaioannou, 2007b), limb muscle and 
tendon formation (Hasson et al., 2010) but not for hindlimb identity or outgrowth.  In humans 
heterozygous loss of Tbx4 causes autosomal dominant Small Patella Syndrome 
(OMIM#147891), characterized by patellar aplasia or hypoplasia and anomalies of the pelvis and 
feet (Bongers et al., 2004).  In adult mice Tbx5 heterozygous mutation produces enlarged and 
dilated atria and ventricles in the heart and subtle forelimb skeletal defects (Bruneau et al., 2001).  
Tbx5 homozygous null mutants die during mid-gestation due to impaired cardiac differentiation 
once the linear heart tube is formed (Bruneau et al., 2001).  Additionally, these mutant embryos 
fail to activate Fgf10 expression resulting in failure of formation of forelimb buds (Agarwal et 
al., 2003).  Tissue-specific ablation of Tbx5 using Prx1-Cre leads to a complete absence of 
forelimb formation (Rallis et al., 2003).  In humans heterozygous loss of Tbx5 results in the Holt 
Oram Syndrome (OMIM #142900). Individuals suffering from this syndrome show upper limb 
malformations and congenital heart defects.  The Tbx5 heterozygous mutant mice are a good 
model for the Holt Oram Syndrome as they have many phenotypic manifestations similar to the 
humans suffering from this syndrome. 
These mutant phenotypes, as well as the phenotypes of all other known mutations in T-





structures during embryonic development.  A list of T-box genes, loss of which results in a 
human phenotype, along with phenotypes of the corresponding mouse orthologs is presented in 
Table 1.1.  However, most of the T-box gene mutations in mouse are embryonic lethal when 
homozygous and mutant embryos die during mid-gestation, hence making it difficult to study the 
role of these genes in organ development beyond mid-gestation.  Efforts to make conditional 
mutations and reporter genes are currently underway, which will enhance our understanding of 
the role of these genes in later stages of development and in the adult. 
1.2  The murine allantois: a model system for the study of blood vessel 
formation  
The allantois is the embryonic precursor of the umbilical cord in mammals and is one of several 
embryonic regions, including the yolk sac and dorsal aorta, that undergoes vasculogenesis, the de 
novo formation of blood vessels.  Despite its importance in establishing the chorioallantoic 
placenta and umbilical circulation, the allantois is frequently, and somewhat inexplicably, 
overlooked in embryological studies.  Nonetheless, the allantois is a highly vascularized tissue 
and recent studies demonstrate the importance to allantois function of vasculogenesis, 
remodeling of the vasculature, and angiogenesis as the allantois invades the chorion.  Thus, the 
allantois has the potential to be a good system to understand the physiological process of blood 
vessel formation. 
Developmental origin and vascular development of the allantois  
The allantois of the mouse emerges from the posterior end of the embryo at the neural plate stage 
of development as a bud of mesoderm derived from the primitive streak (Inman and Downs, 
2006a; Inman and Downs, 2007).  As development proceeds, the allantois grows towards the 





whereby the extracellular spaces increase in volume and accumulate hyaluronic acid (HA) 
(Brown and Papaioannou, 1993). Contact of the allantois with the chorion occurs at the 4-6 
somite pair (s) stage, followed by chorio-allantoic fusion and spreading of the allantois on the 
surface of the chorion to form the chorio-allantoic plate.  The chorion forms the placental villi 
and the vasculature of the allantois grows into these villi to form the labyrinthine layer of the 
placenta (Watson and Cross, 2005) (Figure 1.2).  
The growing allantois, which consists of an outer layer of mesothelium enveloping a 
mesenchymal core, increases in size both  by cell proliferation and by addition of cells from the 
primitive streak (Inman and Downs, 2007).  De novo endothelial cell (EC) differentiation starts 
in the distal allantois as early as the headfold (HF) stage, and is characterized by expression of 
the molecular EC markers Flk1, Pecam and VE-Cadherin (VE-cad) (Drake and Fleming, 2000).    
Starting at the 1s stage, the ECs coalesce in a distal to proximal direction to form vessels in a 
process termed vasculogenesis (Figure 1.3).  These vessels form the primary vascular plexus, 
evident at the 4s stage, which unites with the embryonic and yolk sac circulation at the base of 
the allantois.  The primary vascular plexus remodels to form the umbilical artery and vein 
(Inman and Downs, 2007) which then invade the chorion by sprouting angiogenesis  (Rossant 
and Howard, 2002).  It is still an open question whether or not the allantois contributes to the 
definitive hematopoietic cell lineage.  Cells of the allantois do express markers of hematopoietic 
cell progenitors and can differentiate to form cells of the definitive erythroid and myeloid 






Yolk sac vasculogenesis and dorsal aorta formation 
The visceral yolk sac (VYS), consisting of a mesodermal and an endodermal layer, is another 
site of vasculogenesis and a major site of fetal hematopoiesis.  Clusters of cells within the 
mesoderm form the yolk sac blood islands which contain hemangioblasts, common precursors of 
ECs and hematopoietic cells.  By E8.5, the blood islands contain a single layer of ECs that 
surround the hematopoietic cells.  The ECs then connect to form a continuous primary vascular 
plexus which is remodeled into large and small vitelline vessels (Palis et al., 1995).  Unlike the 
allantois, where ECs migrate through the extracellular matrix of a mesenchymal structure to form 
the primary vascular plexus, the yolk sac vascular plexus forms within a bilaminar epithelial 
structure, between the endoderm and mesothelium.  
Within the body of the embryo, angioblasts, the precursors of ECs, appear in the lateral 
plate mesoderm ventral to the somites and migrate medially to fuse together forming the paired 
dorsal aortae.  The dorsal aortae connect anteriorly with the aortic arteries exiting the primitive 
heart tube and fuse posteriorly to form a single dorsal aorta in the midline of the embryo at the 
level of the forelimbs (Lanzer and Topol, 2002).  The lateral plate mesoderm, similar to the VYS 
but unlike the allantois, is dependent on endodermal signaling for formation of blood vessels.  
Hematopoiesis takes place in the dorsal aorta from hemogenic endothelium lining the blood 
vessels (Dieterlen-Lievre and Jaffredo, 2009). 
Building the allantois vascular network: cellular and extracellular components  
Although the genetic control of vasculogenesis and angiogenesis has been well reviewed in the 
embryo and yolk sac (Patan, 2000; Rossant and Howard, 2002; Patan, 2004; Kowanetz and 
Ferrara, 2006; Ribatti et al., 2009; De Val, 2011; Patel-Hett and D'Amore, 2011), similar 





genes known to be important for differentiation of vascular components and for vascular network 
formation, and examine what is known from mutant analysis about their function in allantois 
vessel formation (Table 1.2).   
Vegf signaling and specification of ECs  
The vascular endothelial growth factor (Vegf) signaling pathway lays the foundation for 
formation of ECs from mesoderm and also plays a major role in angiogenesis.  Vegf and its 
tyrosine kinase receptors, Flk1 (also known as Kdr and Vegfr2) and Flt1 (also known as Vegfr1), 
are critical for development of the vascular system.  Flk1 is the earliest marker of EC 
development (Rossant and Howard, 2002).  In the early yolk sac, Flk1 marks the hemangioblasts 
but later in development its expression is restricted to the EC lineage (Yamashita et al., 2000).  In 
the allantois, Flk1 is expressed at the HF stages in cells that will give rise to the vascular network 
(Drake and Fleming, 2000).  Both Flk1 and Flt1 are expressed in the allantoises of 9-16s stage 
embryos in putative angioblasts and nascent blood vessels (Downs et al., 2001).   Vegf mRNA 
expression has been shown to be confined to the mesothelium of the allantois (Dumont et al., 
1995) whereas protein expression is localized to both mesothelial and core cells (Downs et al., 
2001).  Thus, similar to other sites in the embryonic vasculature, Vegf expression in the allantois 
is associated with active Flk1 expression and is suggestive of Vegf’s role in the induction and 
maintenance of EC fate.  Later in development both Flk1 and Flt1 are expressed in the 
labyrinthine vasculature of the placenta and associated labyrinthine trophoblasts, whereas the 
labyrinthine stromal cells express Vegf (Dumont et al., 1995).  
Loss of one allele of Vegf by targeted mutagenesis results in lethality and affects 
vasculogenesis and angiogenesis in both embryo and yolk sac (Carmeliet et al., 1996; Ferrara et 





mutants, it was suggested that the endothelium lining the fetal placental vasculature degenerated 
(Ferrara et al., 1996).  Targeted mutation of the Flk1 gene resulting in a null allele causes 
embryonic lethality at E9 with both embryo and allantois showing a lack of mature ECs (Shalaby 
et al., 1995).  On the other hand, Flt1 null mutants show a disorganized embryonic and yolk sac 
vasculature and possibly an overgrowth of ECs, suggesting an inhibitory role for this receptor in 
vascular development (Fong et al., 1999).  However, the allantois endothelium was not examined 
in Flt1 mutants.  In addition, Vegf coreceptors, neuropilin 1 (Np1) and neuropilin 2 (Np2) are 
important for vascular development.  Embryos double mutant for Np1 and Np2 die around E 8.5 
and show an absence of vasculature in the yolk sac and embryo.  Here again, the allantois was 
not examined in the double mutants and the expression of Np1 and Np2 in the allantois has not 
been determined (Takashima et al., 2002).    
The supporting mural cells of the allantois  
Mural cells, which include pericytes and smooth muscle cells (SMC), support the developing 
vasculature (Figure 1.3) and are characterized by the expression of platelet derived growth factor 
receptor β (PDGFRβ).  The ligand for this receptor, PDGFB, is secreted by immature ECs and 
promotes the differentiation of the surrounding mesenchyme and the recruitment of mural cells 
(Betsholtz et al., 2001).  Both PDGFRβ and PDGFB null mutants show defective smooth muscle 
recruitment in the embryo and the placenta, with disorganized and dilated vasculature (Ohlsson 
et al., 1999).  
Extracellular matrix in the allantois  
Extracellular matrix (ECM) is essential during vessel formation for the adhesion, migration, 
proliferation and vascular organization of ECs (Figure 1.3) (Hynes et al., 2002; Stupack and 





ECM components are known to be important for development of the vasculature but only a 
handful have been implicated in allantois vasculogenesis.  Fibronectin (Fn) and its binding 
partner α5 integrin (Itgα5) are both necessary for EC tube formation.  Fn and Itgα5 are both 
expressed in the allantois and mutations in either affects chorio-allantoic fusion (George et al., 
1993; Francis et al., 2002) although the vasculature of mutant allantoises has not been analyzed.  
Embryonic stem cell-derived embryoid bodies (EBs) have been used as a model to study blood 
vessel formation.   EBs lacking Fn or Itgα5 differentiate to form ECs but these fail to form 
tubular structures (Francis et al., 2002). 
In addition to matrix proteins, the proteoglycan HA is important for angiogenesis and, 
depending on the context, can act as a pro- or anti-angiogenic agent (West et al., 1985; Tempel et 
al., 2000).  HA is present in the allantois (Fenderson et al., 1993).   It is synthesized by 
hyaluronic acid synthase 2 (Has2), which is expressed in the allantois  (Tien and Spicer, 2005).   
Mutation in Has2 produces defects in endocardial cushion formation in the heart, but the 
allantois vasculature has not been analyzed (Yamamura et al., 1997; Camenisch et al., 2000). 
Another category of ECM molecules important for vascular morphogenesis is the 
metalloproteases, which includes MMPs, TIMPs, ADAMs and the ADAMTS family of proteins.  
In this category, only ADAMTS9 is known to be expressed in the allantois (Jungers et al., 2005).  
ADAMTS9 is an EC-autonomous inhibitor of angiogenesis and also a tumor suppressor.  
ADAMTS9 null mutants die prior to gastrulation hence its role in vasculogenesis has not been 
analyzed (Koo et al., 2010).  
Building the allantois vascular network: signaling pathways and transcription 
factors 





The angiopoietin-Tie signaling pathway has been implicated in branching, remodeling and 
stabilization of the vascular plexus.  The ligands angiopoietin1 (Ang1) and angiopoietin 2 (Ang2) 
and the endothelial-specific receptor tyrosine kinases, Tie1 and Tie2 (also known as Tek) interact 
to remodel the primary vascular plexus.   Both Tie1 and Tie2 are expressed in allantoises at the 
9-16s stage (Downs et al., 2001).  Ang2 expression has been reported in the allantois at 
approximately the 30s stage (Yuan et al., 2000) but has not been investigated earlier;  expression 
of Ang1 has not been investigated in the allantois.  Both Tie2 (Sato et al., 1995) and Ang1 (Suri 
et al., 1996) homozygous null mutants show dilation of blood vessels, defects in vascular 
remodeling, vessel sprouting and branching, suggesting a role for these genes in  EC interactions 
with the surrounding mesenchyme and ECM.  Tie1 null mutants die at birth due to hemorrhage 
and lack of vascular integrity (Sato et al., 1995).  Ang2 acts as a negative regulator of Ang1-Tie2 
interactions.  Ectopic expression of Ang2 under the control of the Tie2 promoter results in an 
angiogenic remodeling phenotype similar to the lack of Tie2 or Ang1 (Maisonpierre et al., 1997).  
The allantois vasculature has not been analyzed in any of these mutants although the umbilical 
vessels in the Ang1 nulls reportedly show a lack of complexity (Suri et al., 1996). 
The Tgfβ signaling pathway has also been implicated in vascular remodeling.  Tgfβ and 
its downstream effectors Activin receptor like kinase 1 (Alk1) and Alk5 (also known as TβR1) are 
all involved in angiogenesis (Rossant and Howard, 2002).  Tgfβ1 is expressed in the allantois 
(Akhurst et al., 1990) and null mutants for Tgfβ show defects in vascular network formation in 
the yolk sac and allantois.  Some of the mutants also show an absence of chorio-allantoic fusion 
(Dickson et al., 1995).  ECs derived from Alk5 null mutant embryos show defective migration in 
in vitro assays.  Additionally, Alk5 mutants show defects in infiltration and sprouting of the 





Signaling pathways involved in differentiation between arteries and veins  
Differentiation of blood vessels into arteries or veins was once assumed to be the result of 
physical differences such as oxygenation, blood pressure and shear forces but over the last 
decade it has been recognized that artery and vein distinction is inherently programmed.  Two 
types of molecules, the ephrins and Notch family molecules, have been identified as molecular 
markers for this differentiation process (Rossant and Howard, 2002).   EphrinB2 an Eph family 
ligand is expressed in the arterial system and conversely the receptor Eph-B4 is expressed in the 
venous system (Wang et al., 1998).  Deficiency of either of these molecules produces a similar 
phenotype of loss of angiogenesis in both arteries and veins, presumably due to a lack of 
interaction and hence lack of differentiation of the capillary beds (Wang et al., 1998; Gerety et 
al., 1999).  Similar to the embryonic and yolk sac vasculature, the ligand ephrinB2 is expressed 
in the umbilical artery and the receptor Eph-B4 is expressed in the umbilical vein (Wang et al., 
1998). 
In addition, it has been shown that Notch family members Notch1, Notch3, Notch4, 
Delta-like 4 (Dll4), Jagged1 (Jag1) and Jagged2 are all expressed in arteries (Villa et al., 2001).  
Notch signaling pathway lies upstream of ephrin signaling and has been implicated to drive 
arterial differentiation (Lin et al., 2007).  Notch2 is expressed in the allantois; the death of 
Notch2 null mutants at E10.5 has been ascribed to apoptosis in the embryo, although the allantois 
and placental vasculature were not analyzed (Hamada et al., 1999) and could play a contributing 
role.  Loss of one allele of Dll4 by targeted mutagenesis results in lethal haploinsufficiency.  
Heterozygous mutants display degenerating vasculature in the placental labyrinth (Gale et al., 
2004).  Mutation in Jag1 leads to yolk sac and embryonic vasculature defects, but the allantois 





helix transcription factors Hey1 and Hey2 (also called Hes) are activated downstream of Notch 
signaling and act as transcriptional repressors.  Both Hey1 and Hey2 are expressed in the 
allantois from E8.5 (Leimeister et al., 1999).  Loss of both Hey1 and Hey2 leads to a vascular 
phenotype similar to the ephrinB2 ligand or Eph-B4 receptor null mutants where there is a defect 
in the remodeling of the vasculature.  Indeed, Hey1 and Hey2 double mutants show a loss of 
ephrinB expression in vascular tissues.  The allantois of double mutants attaches to the chorion 
and although the chorionic vessels form, they fail to invade  the placental labyrinth (Fischer et 
al., 2004). 
Dependence of vascular network formation on hedgehog signaling  
Flk1-positive angioblasts of the VYS organize into vascular channels in vitro only in the 
presence of a visceral endodermal layer, suggesting that signals from the endoderm are essential 
for vascular network formation.  On the other hand, the yolk sac mesodermal layer differentiates 
into Flk1-positive angioblasts upon culture in the presence or absence of the adjacent 
endodermal layer (Palis et al., 1995).  In the absence of endoderm, Ihh, one of the ligands for the 
hedgehog (Hh) signaling pathway,  can induce a vasculogenic  program in anterior epiblast cells 
in vitro  (Dyer et al., 2001).  Furthermore, EBs lacking Ihh or smoothened (Smo), the receptor for 
Hh ligands, form Pecam-positive ECs that fail to form endothelial tubes (Byrd et al., 2002).   
Additionally, Hh signaling from the endoderm is essential to promote vascular network 
formation in the embryo (Byrd and Grabel, 2004)  highlighting the role of Hh signaling in blood 
vessel formation in different vasculogenic systems.  A Smo null mutation, which results in 
abrogation of all Hh signaling, provides evidence that Hh signaling has different functions in 
development of the dorsal aorta, yolk sac and allantoic vasculature:  In the anterior region of 





et al., 2004); in the yolk sac, Pecam-positive ECs connect to form a primary vascular plexus but 
fail to remodel into a mature vascular network (Astorga and Carlsson, 2007);  in the allantois, 
there is no apparent effect on vessel formation.  Thus, the loss of Hh signaling affects 
vasculogenesis in the dorsal aorta, angiogenesis in the yolk sac, but neither of these processes in 
the allantois.  
Hh signaling regulates vessel formation by regulation of the transcription factor Foxf1 
and its downstream effector, Bmp4, in the yolk sac and developing embryo.  However, Foxf1 
expression is independent of Hh signaling in the posterior end of the primitive streak and the 
allantois, perhaps explaining why loss of Hh signaling does not affect allantois vasculogenesis.  
Allantois vascular development is nonetheless dependent on Foxf1 as mutations in Foxf1 
produce vascular phenotypes in dorsal aorta, yolk sac and allantois (Astorga and Carlsson, 2007).  
Wnt and Bmp signaling in blood vessel formation 
The canonical Wnt family member, Wnt2 plays important roles in EC proliferation and vascular 
network formation in two in vitro systems, hepatic sinusoidal ECs (Klein et al., 2008) and EBs 
(Wang et al., 2007).  Wnt2 is expressed in the allantois throughout its growth and vascularization 
and Wnt2 null mutants show placental defects during late gestation (Monkley et al., 1996). 
Endothelial-specific loss of β-catenin, the downstream effector of canonical Wnt signaling, 
affects vessel diameter in the yolk sac, umbilical vessels and the cephalic plexus. Additionally, 
the placentas from these mutants show a reduced number of fetal blood vessels in the 
labyrinthine layer (Cattelino et al., 2003).  Rspo3, a secreted protein that can activate the 
canonical Wnt signaling pathway, is important for activation of Vegf (Kazanskaya et al., 2008).  





invade the placenta and to vascular defects in the yolk sac (Aoki et al., 2007; Kazanskaya et al., 
2008). 
Non-canonical Wnt5a and Wnt11 affect EC proliferation, migration and network 
formation in vitro (Masckauchan et al., 2006; Cheng et al., 2008; Stefater et al., 2011).  Both 
Wnt5a and Wnt11 expression have been observed in the allantois (Kispert et al., 1996; 
Yamaguchi et al., 1999; Majumdar et al., 2003).   Mutation of Wnt5a leads to a shortening of the 
A-P axis of the embryo, although it does not affect development of the allantois (Yamaguchi et 
al., 1999).  Most Wnt11 null mutants are embryonic lethal before midgestation, but the cause of 
death has not been determined (Majumdar et al., 2003) and, thus, Wnt11 might affect the 
development of allantois or placental vasculature.   
Bmp4 is implicated in induction of mesoderm and differentiation of mesoderm into ECs 
(Moser and Patterson, 2005).  Loss of Bmp4 leads to a deficiency in the amount of mesoderm 
resulting in aberrant yolk sac blood island formation and a small or absent allantois (Winnier et 
al., 1995).  Mutation of Smad1, a downstream effector of BMP signaling, results in defective 
chorio-allantoic fusion, but the vasculature of the allantois has not been analyzed (Tremblay et 
al., 2001). 
Transcription factors important for blood vessel formation 
A number of transcription factors are involved in EC and blood vessel formation in the embryo 
and yolk sac.  A few have been investigated in the allantois including Etv2, Snai1 and dHand.   
Etv2 (also known as ER71 or Etsrp71) is expressed in the allantois at E7.5 and E8.25.  Etv2 is 
important for EC identity; Etv2 homozygous null mutants are devoid of ECs in the embryo, yolk 
sac, amnion and the allantois (Lee et al., 2008).  Additionally, in these mutants the placental 





transcriptional repressor, Snai1, is important for mesoderm formation and its epiblast-specific 
deletion results in vascular defects throughout the embryo.  ECs differentiate but fail to coalesce 
into a primary vascular plexus in the embryo or the allantois (Lomeli et al., 2009).  dHAND, a 
basic helix loop helix transcription factor, is expressed in the developing vascular SMCs and 
their precursors.  Lack of dHAND results in disorganized vasculature in the yolk sac and embryo, 
possibly due to regulation of Np1 by dHAND (Yamagishi et al., 2000).  dHAND is expressed in 
the allantois although the allantoises and the placentas in dHAND mutants have not been 
analyzed (Charite et al., 2000). 
T and Tbx4, two members of the T-box family of transcription factor genes have been 
implicated in the process of vasculogenesis in the developing allantois.   Both of these genes are 
expressed in the allantois starting E7.5.  T is expressed until the 4-6s stage, whereas Tbx4 is 
expressed at least until the formation of umbilical vessels at E10.5 (Inman and Downs, 2006b; 
Naiche et al., 2011).  Loss of function mutation in either of these genes leads to absence of 
chorio-allantoic fusion and a lack of vascular plexus formation, although the ECs differentiate 
and express Pecam (Naiche and Papaioannou, 2003; Inman and Downs, 2006a) 
Methods for allantois culture ex vivo 
The allantois has many advantages as a system to study blood vessel development.  First, it can 
be isolated from the embryo and cultured ex vivo.  Because the allantois contains mesodermal 
cells capable of differentiating into ECs in response to signals provided by the mesothelium, 
mesenchyme and surrounding ECM, also present in the explant, it is a self-contained system with 
the potential to undergo vasculogenesis or angiogenesis in vitro.  When isolated early (HF-1s 
stage), explants undergo vasculogenesis and when isolated later (4-6s stage), they undergo 





microscopy to follow the sequence of events that occur during vessel formation in vitro (Perryn 
et al., 2008).  Finally, cultured allantois explants can be immunostained for markers of vessel 
formation and can be sectioned for histological analysis (Downs et al., 2001; Downs, 2006).  
Several ex vivo culture methods have been developed to analyze different aspects of blood vessel 
formation as discussed below. 
Adherent allantois culture 
The most commonly used method to culture the allantois is in serum-containing media on tissue 
culture plastic or glass coated with poly-D-lysine or fibronectin for up to 72 hours (Downs et al., 
1998; Downs et al., 2001; Perryn et al., 2008).  After 4-6 hours, the distal tip of the allantois 
attaches to the plastic or glass and mesenchymal cells begin to spread.  By 12 hours the entire 
allantois is firmly attached.  As occurs in vivo, the explant begins vascularization at the distal end 
of the allantois.  The vascular plexus expands on top of and in communication with the 
mesenchymal layer of cells.  By 18-20 hours of culture the explant adopts a circular shape with 
the vascular plexus covering the entire area except at the periphery, which is populated only by 
mesenchymal cells (Downs et al., 2001) (Figure 1.4).  As shown histologically, vessels of the 
plexus form lumens in vitro (Argraves et al., 2002).  Explants show expression of all EC markers 
seen in vivo, namely Flk1, Flt-1, Tie1, Tie2, Pecam and VE-Cad. The mesothelium of allantois 
explants can be identified with VCAM-1 staining and is present on top of the vascular plexus 
(Downs et al., 2001; Downs, 2006).    
Allantois suspension culture 
An alternative culture method that better preserves the 3-dimensional (3D) structure of the 
allantois is suspension culture in rolling tubes.  With this method, isolated allantoises round up 





structures can be sectioned to study histomorphology and gene expression patterns in detail 
(Downs et al., 2001; Downs, 2006).  
Allantois hanging drop culture 
Another method that preserves 3D structure is the hanging drop culture that generates allantoic 
spheroids of mean diameter 440µm. These spheroids contain a 3D network of Pecam-positive 
endothelial tubes and an outer layer that stains for SMC markers α smooth muscle actin (αSMA), 
SM22α and smooth muscle myosin.  Upon addition of VEGF to the culture media,  vessels in the 
core fuse to form uniluminal vascular spheroids characterized by an inner Pecam-positive EC 
layer and a closely associated outer layer of αSMA-positive cells. This culture system provides a 
means to study interactions between ECs and SMCs (Gentile et al., 2008).   Furthermore, when 
two uniluminal spheroids are placed in contact with one another in the presence of VEGF, the 
spheroids fuse to form a single large spheroid modeling the fusion of the paired dorsal aortae in 
the developing embryo (Fleming et al., 2010). 
Allantois culture for the derivation of hematopoietic cells 
Tal1(Drake and Fleming, 2000) and CD41 (Corbel et al., 2007), markers for hematopoietic 
progenitors, and Runx1 (Zeigler et al., 2006), a marker for the definitive hematopoietic lineage, 
are all expressed in the pre-fusion allantois.  Despite the presence of these markers, it is not 
certain whether the allantois gives rise to hematopoietic cells in vivo.  However, the allantois 
does have the potential to form hematopoietic cells in vitro.  When multiple allantoises are 
cultured together for 2-5 days, dissociated to a single cell suspension and seeded in media 
containing methylcellulose and cytokines, the cells show myeloid and erythroid differentiation in 





Use of adherent allantois cultures to study gene function in blood vessel formation 
VE-Cad function and signaling in blood vessel formation 
VE-Cad is specifically expressed by ECs at cell-cell adherens junctions. Embryos that lack VE-
Cad gene function show impaired vascular development; mutants die at E9.5 due to a failure of 
vessel remodeling and maturation (Gory-Faure et al., 1999).  Although initial EC differentiation 
occurs, the mutant phenotype is complex and which subsequent step of vasculogenesis is 
affected is controversial (Carmeliet et al., 1999; Gory-Faure et al., 1999).  One interpretation is 
that ECs in the allantois and yolk sac fail to form a vascular plexus; the alternative interpretation 
is that plexus formation proceeds normally but subsequent stabilization of the plexus fails, 
leading to its disintegration (Carmeliet et al., 1999; Crosby et al., 2005). 
Allantois cultures with or without a VE-Cad blocking antibody (Ab) were used in two 
studies to address these alternative hypotheses.   Culture of wild type allantoises in the presence 
of VE-Cad Ab results in a phenotype identical to culture of VE-Cad null mutant allantoises, that 
is, the presence of Pecam-positive ECs but absence of a vascular plexus (Crosby et al., 2005).  In 
the first study, early wild type allantoises were cultured with VE-Cad Ab either during the early 
phase of culture followed by culture in the absence of VE-Cad Ab or vice versa. When the VE-
Cad Ab was added during the initial phase of culture, vascular plexus formation was not 
affected.  When the antibody was added in the later phase, the plexus showed disconnected 
clusters of ECs. These results were interpreted as a disassembly of the vascular plexus which 
would suggest a role for VE-Cad in plexus stabilization, rather than plexus formation (Crosby et 
al., 2005). However, an alternate explanation is that loss of VE-Cad function affects EC motility.  
In a second study, this possibility was examined using time lapse imaging. Wild type 
allantoises were cultured in the presence of Cy3-CD34, an antibody which immunolabels ECs 





period of vessel formation (Perryn et al., 2008).  Using this method, EC movements can be 
studied in the presence of independent movement of the allantois mesenchyme and mesothelium, 
mimicking the in vivo scenario of blood vessel development. The major findings of this study 
were that new interconnections of ECs are formed a) by gradual enlargement of an avascular 
area and b) by vasculogenic sprouting involving initiation and extension of a vascular cord until 
it meets another cord.  As a new sprout extends and interacts with the surrounding matrix, new 
ECs are added to the sprout from the EC cluster at the site of sprout initiation. Treatment with a 
VE-Cad Ab does not prevent sprout initiation but prevents addition of ECs to the extending 
sprout.  Without the addition of ECs, the sprouts regress and fail to form new interconnections to 
make a vascular plexus.  In addition, movement of the ECs, independent of the movement of the 
mesenchymal or mesothelial layers, was reduced by 50% in the presence of VE-Cad Ab (Perryn 
et al., 2008).  Allantois culture in conjunction with live imaging has thus helped resolve the 
function of VE-Cad as being important to EC-autonomous motility, contribution of ECs to sprout 
formation and vascular plexus formation.  However, an additional role for VE-Cad in vascular 
plexus stability has not been ruled out. 
Role of lipids in angiogenesis 
Sphingosine-1-phosphate (S1P) is a phospholipid generated by the phosphorylation of 
sphingosine by sphingosine kinase (SK). S1P binds to one of its receptors S1P1-S1P5 and 
activates Ras and ERK signaling to promote cell survival. S1P plays a role in different processes 
important for blood vessel formation including EC migration, chemotaxis, cytoskeletal 
reorganization and adherens junction assembly but being a lipid its precise role cannot be 
determined using in vivo mutagenesis.  S1P1 regulates vessel stabilization by recruitment of 





embryo during vasculogenesis.  In serum-deficient conditions, cultures of early allantoises (E7.8) 
form Pecam-positive ECs but fail to form a vascular plexus while allantoises cultured from later 
embryos (E8.5) show limited plexus forming ability. S1P rescues vascular plexus formation, by 
promoting expansion of the vascular network and the mesothelial layer in serum-deficient 
allantois cultures.  S1P treatment of allantoises cultured with or without serum, did not alter the 
number of ECs or mesodermal cells.  Thus, using the allantois as a model system revealed that 
S1P does not affect endothelial, angioblast or mesenchymal cell number but instead affects the 
degree of expansion of the vascular network, suggesting a potential role in EC migration in 
vasculogenesis (Argraves et al., 2004). 
Autotaxin (ATX) a protein involved in lipid metabolism converts lysophosphatidyl 
choline to lysophosphatidic acid (LPA) and sphingophosphocholine to S1P in vitro.  Embryos 
homozygous for a mutation in the ATX gene Enpp2 show severe vascular defects while 
heterozygous adult mice show decreased circulating levels of LPA, suggesting ATX might 
function through the production of LPA in vivo.  Vascular plexi of wild type allantois explants 
readily disintegrate when serum is removed from the culture media.  This disintegration can be 
prevented by addition of ATX or LPA. Thus, these molecules are essential for maintenance of 
the vascular plexus (Tanaka et al., 2006). 
Other gene functions established using allantois culture system 
Deficiency of RA-GEF1, a guanine nucleotide exchange factor for the small GTPase Rap1, leads 
to impaired vascular development and decreased plexus formation in allantois cultures as 
measured by vessel sprout formation (Kanemura et al., 2009).  ECs from RA-GEF1 null allantois 
explants show a decrease in VE-Cad expression and a lack of GTP bound RAP1.  VE-Cad 





active, GTP-bound form of RAP1 and cultured with mouse stroma cells.  Additionally, when 
mutant allantoises are isolated, transfected with constitutively active RAP1 and cultured in 
collagen gels, an increase in vessel sprout formation is noted. Thus the allantois culture system 
was used to show that RA-GEF1 regulates vascular network formation by controlling RAP1 
activation and VE-Cad expression in ECs (Kanemura et al., 2009). 
Other gene functions established using the adherent allantois culture system are a role of 
PDGFB in vascular outgrowth (French et al., 2008), BMP signaling in SMC differentiation 
(Astorga and Carlsson, 2007), histone deacetylase (HDAC) in commitment of progenitor cells to 
an EC fate (Rossig et al., 2005),  VE-PTP in remodeling of vasculature (Baumer et al., 2006), 
Gas1 in EC survival (Spagnuolo et al., 2004), PI3K and ARAP3 in sprout formation 
(Gambardella et al., 2010) (Table 1.3). 
Applications in disease and therapeutics 
Apart from its importance in normal embryonic development, blood vessel formation plays a key 
role in many pathological conditions such as cancer, diabetic retinopathy, rheumatoid arthritis, 
obesity, age related macular degeneration and neurological disorders such as Parkinson’s and 
Alzheimer’s disease (Aisha et al., 2010).  Thus systems that model blood vessel formation are 
valuable not only for understanding basic mechanisms of vessel formation but also for screening 
drugs that influence vessel formation.  Although in vitro model systems are available that utilize 
cultured EC lines, these models have limitations.  First, they may have acquired properties that 
facilitate perpetuation during derivation in vitro that could influence their responses to drugs.  
Further, being homogenous EC cultures, they lack the presence of any mural cells or ECM that 
provides a tissue-type environment.  Allantois cultures, on the other hand, have the advantages of 





vessel formation.  Thus the effect of drugs or small molecules on all the processes of vessel 
formation – EC proliferation, EC migration, endothelial tube formation and formation of an EC 
vascular network – can be determined in one system that closely mimics in vivo vessel 
formation. Additionally this culture system is robust and reproducible. Methods for 
quantification of different parameters in this system are now available (Zudaire et al., 2011).  
Because there is no standard model that can mimic an in vivo disease situation completely, the 
combined use of EC cell lines and allantois explants provides for a good drug screening strategy 
to study the effects of the drugs on blood vessel formation. 
Conclusion 
In conclusion, the use of the allantois to study blood vessel formation is in its infancy although 
the studies reviewed here amply illustrate its usefulness.  The allantois culture methodology 
allows teasing out function when a vascular defect results in early lethality and can be used to 
distinguish if a vascular phenotype is primary or secondary to the loss of gene function 
elsewhere in the embryo.  Finally, the allantois explant culture provides an additional in vitro 
system for drug screening and establishing drug efficacy as pro- or anti-angiogenic.  Thus, the 
allantois is emerging as an important tool to study vasculogenesis and angiogenesis in 
development and disease. 
Known role of T-box genes in vascular development 
There are a few examples of T-box transcription factors being involved in vessel development.   
Tbx1 is required for the appropriate patterning of the pharyngeal arch arteries, aortic arch arteries 
and the proximal coronary arteries (Vitelli et al., 2002a; Theveniau-Ruissy et al., 2008).  Upon 
myocardium injury in zebrafish, epicardial cells begin to express Tbx18 along with increased 





(Lepilina et al., 2006).  This suggests a potential role for Tbx18 for epicardial cell EMT or 
subsequent migration during coronary vasculogenesis. Tbx5 may also regulate vessel formation 
by affecting migration of epicardial cells (Hatcher et al., 2004).  Tbx5 may also have a 
cytoplasmic localization in cells of the coronary vasculature (Bimber et al., 2007) further 
suggesting a potential role in vasculogenesis.  Mutation in mouse Tbx3 results in reduced yolk 
sac vasculature and high levels of apoptosis in the yolk sac endodermal layer (Davenport et al., 
2003).   
Loss of Tbx4 does not affect EC differentiation in the allantois, but does affect the ability 
of these ECs to form vessels and a vascular plexus (Naiche and Papaioannou, 2003).  Although 
Tbx4 leads to a vascular phenotype in the allantois, it is not expressed in the allantoic ECs or the 
ECs of the umbilical vessels (Naiche et al., 2011).  The allantois adherent cultures provide for a 
good system to characterize the Tbx4 mutant phenotype in detail and to understand the role of 
Tbx4 in vascular development of the allantois. 
1.3  Development of the respiratory system 
The mammalian respiratory system, comprising of the lung and trachea, originates from the 
ventral aspect of the foregut tube.  During the course of development the lung epithelium follows 
a stereotypic pattern of branching morphogenesis in close proximity to a branching vascular 
network.  The branching epithelium ultimately differentiates into alveolar epithelial cells 
adjacent to a capillary network and together these form the functional units of the respiratory 
system, allowing for exchange of gases within the blood circulation.  Multiple signaling 
pathways including the Fgfs, Wnts, Retinoic acid and the Bmps have been implicated in different 





Specification of the respiratory system 
The endodermal foregut tube is patterned by cues from the lateral plate mesoderm leading to 
specification of specialized endodermal organs. Expression of transcription factors or markers 
characteristic of specific organs are observed along the anterior posterior axis of the foregut tube 
before formation of each organ. Pax8 and Nkx2.1 specifically mark the thyroid endoderm, 
Albumin marks liver endoderm, Pdx1 marks the pancreatic endoderm and Somatostatin marks 
the intestinal endoderm (Serls et al., 2005).  Nkx2.1 has been identified as the earliest marker of 
lung endoderm specification and is expressed at embryonic day (E) 9.0 (19-24 somites) in the 
mouse (Figure 1.5).  Outgrowth and branching of these Nkx2.1 expressing cells require 
fibroblast growth factor (FGF) signaling. FGF signaling centers from the heart and/or from the 
splanchic mesenchyme influence lung formation from foregut endoderm. The dose and timing of 
exposure of endodermal precursors to FGF signaling from the cardiac mesenchyme influences 
the formation of pulmonary lineages. Cells receiving less FGF stimulation form other organs 
including the gastrointestinal tract, liver and pancreas (Zaret, 2002). Recent evidence using in 
vitro foregut culture suggests that induction of mesenchymal Fgf10 in the prospective lung field 
is dependent on retinoic acid (RA) signaling pathway and this control of RA is selective for the 
mid-foregut region and occurs within a defined developmental window before primary budding 
(Desai et al., 2004). In addition, using this system it has been shown that RA acts as a major 
regulatory signal integrating Wnt and Tgfβ pathways in the control of Fgf10 induction in the 
foregut mesoderm (Chen et al., 2010).  Also, combined loss of Wnt2 and Wnt2b, which are 
expressed in the mesoderm surrounding the anterior foregut, or of β-catenin in the endoderm, 
leads to loss of Nkx2.1 expression and failure of lung specification (Goss et al., 2009; Harris-





pathways have been implicated as important for specification of the lung/trachea primordia 
(Figure 1.5).  
After specification, at E9.25 (25-28 somites) the primary lung buds appear as ventral 
outpouchings of the foregut (Cardoso and Lu, 2006).  Whether there is a single bud, which later 
subdivides and develops the two lung buds or whether the endodermal lung primordia originate 
from primarily paired primordia is controversial.  Recent evidence using scanning electron 
microscopy in the chick supports the latter hypothesis (Metzger et al., 2011).  After the lung buds 
appear they grow in a ventro-posterior direction to eventually fuse together at E9.5 (~30 somites) 
and continue to elongate until E11.5.   
Lung branching and morphogenesis 
In the mouse, the left lung bud remains a single lobe and the right lung bud branches to form 4 
lobes - cranial, medial, caudal and accessory (Cardoso and Lu, 2006).  The lobes undergo a 
stereotypic pattern of branching between E11.5 and E16.5, the pseudoglandular phase. Timed 
analysis of branch formation in the lungs suggests that the branching pattern can be broken down 
into three distinct modes that are used repeatedly in different combinations. The first mode is 
called domain branching involving new bud formation at specific distances from the tip of a stalk 
and at positions around the circumference that are either dorsal/ventral or medial/lateral relative 
to the axis of the parent stalk. The other two modes relate to the bifurcation of the tip and are 
either planar or orthogonal bifurcations depending on the axis along which the two new buds 
form (Metzger et al., 2008).  From E16.5 to E17.5, the canalicular stage, the terminal buds 
become narrower and from E18.5 to post natal day 5, the saccular stage, the precursors of the 





Vascular development in the branching lung 
The adult lung has a dual vascular system, the bronchial and the pulmonary system. The 
bronchial system delivers oxygen to all non respiratory structures of the lung, whereas the 
pulmonary system transports deoxygenated blood to the alveoli where gas exchange occurs. The 
pulmonary arteries arise from the pulmonary trunk of the heart and closely follow the bronchial 
tree, giving rise to the alveolar capillary plexus. These capillaries drain into the pulmonary veins, 
which connect back to the left atrium of the heart. A detailed analysis of the pulmonary 
vasculature from the earliest embryonic stage suggests that the vasculature is a part of the 
embryonic circulation from the moment the lung starts to develop. Hence the presence of blood 
vessels is potentially important for the development of the lung. For example, the ECs of the 
splanchic mesoderm may be involved in the prepatterning and induction of the presumptive lung 
region as has been shown for liver and the pancreas (Parera et al., 2005).  
Distal angiogenesis has been proposed as a model for pulmonary vasculogenesis, that is, 
lung vasculature develops from preexisting vessels (Parera et al., 2005). The tip zone, which is 
the distal part of the branching airway that lacks the layer of SMCs, is covered by a network of 
capillaries. This network expands as the lung bud grows and finally leads to the alveolar 
capillary plexus. The epithelial-endothelial interactions induce angiogenesis at the tip zone, 
which ensures that the vascular network proceeds alongside epithelial branching. New vessels 
undergo vascular remodeling, implying that some vessels grow and fuse with neighboring 
vessels, whereas others remain small or degenerate (Parera et al., 2005). Once the vascular 
network is set up it is maintained by the presence of vascular SMCs that surround the blood 
vessels. The mesothelium of the lung contributes to mesenchymal cells within the lung and in 





Innervation of the branching lung 
The innervations and the airway smooth muscle (ASM) have recently been recognized as 
integral components of the developing lung: both are present in the epithelial tubules of the 
embryonic lung bud shortly after it evaginates from the foregut. Whereas, the ASM is 
functionally mature shortly after it is laid down, the growth and maturation of the innervations 
largely follows the morphological stages of development. The neural tissue and the ASM are 
integral part of the lung, and persist in a dynamic state throughout gestation and into postnatal 
life and late adulthood (Harding et al., 2003).   
Two large nerve trunks lying in the outermost surface of the airway wall span the 
complete length of the bronchial tree. They give rise to a network of bundles which cover the 
ASM from the trachea to the growing tips of the airways. The maturation of nerve trunks and 
ganglia occurs as the bronchial tree expands throughout gestation until the end of the canalicular 
stage (Tollet et al., 2001). 
Little is known about the structural relationship between nerves and smooth muscle 
during early lung development. Neural stimulation leads to contraction of ASM in first trimester 
fetal pigs. The ASM is functionally mature as it responds by contracting to multiple agonists 
such as acetylcholine, histamine, and substance P, and by relaxing to β-adrenoreceptor agents 
(Sparrow et al., 1994). ASM may function as a mechanical prerequisite for lung growth by 
generating a positive pressure in the liquid-filled tubules. Studies have shown that a maintained 
pressure in the lung liquid is necessary for normal lung growth (Harding et al., 2003). ASM tone 
and spontaneous contractions are implicated in lung growth possibly by inducing the expression 





Signaling pathways implicated in lung branching 
Given that lung branching follows a stereotypic pattern, it is hypothesized that specific gene 
expression patterns would allow branching routines to occur at defined intervals. An example 
that supports this hypothesis is that loss of either Fog2 or Gata4 leads to a loss of the accessory 
lobe in the right lung (Ackerman et al., 2005; Ackerman et al., 2007). Additionally, hedgehog 
interacting protein 1 (hip1) null mutants display one right and one left lobe suggesting that they 
fail to complete the first step in branching morphogenesis – the lobation of the right lung into 
four lobes (Chuang et al., 2003).  
The stereotypic pattern of lung branching has only been described recently (Metzger et 
al., 2008).  Thus, most of the genes important for lung branching have been studied in the 
context of how these genes signal to facilitate growth of a proximal lung bud and branching of 
the distal tip. Genes involved in different signaling pathways, including Fgf, Wnt, Bmp, Shh and 
retinoic acid synthesis have been shown to play important roles in lung branch formation.  
Fgf signaling in lung branching 
Fgf10 which is expressed in the mesenchyme is primarily responsible for branching of the 
epithelial tips (Weaver et al., 2000). Fgf10 mutants form the lung buds but fail to undergo 
branching and the lung buds degenerate with time (Min et al., 1998; Sekine et al., 1999).  
Mutation in the IIIb isoform of Fgfr2, which is the primary receptor for Fgf10 in the lung, results 
in a very similar phenotype as a mutation in Fgf10 where null mutants show a complete absence 
of lungs at birth (Arman et al., 1999).  Fgf9, which is expressed in the early epithelium and the 
mesothelium, promotes expression of Fgf10 and Wnt2 in the distal mesoderm and is thought to 
be the Fgf that regulates lung mesenchyme (Yin et al., 2008).  Recently it has been shown that 





mesenchymal proliferation and that epithelium-derived Fgf9 affects epithelial branching (Yin et 
al., 2011).  
Bmp signaling in lung branching 
Inhibition of epithelial Bmp4 signaling by overexpression of Xnoggin leads to a decrease in lung 
size and irregularly shaped lung lobes (Weaver et al., 1999).  Over-expression of Bmp4 also 
results in smaller lungs with reduced branching and distended terminal buds (Bellusci et al., 
1996).  Abrogation of lung epithelial-specific Smad1 – a downstream effector of Bmp signaling 
– results in retardation of lung branching morphogenesis and neonatal respiratory failure (Shu et 
al., 2002; Xu et al., 2011).  
Wnt signaling in lung branching 
Wnt7b is expressed in the airway epithelium and Wnt7b mutants show lung hypoplasia due to 
defects in mesenchymal proliferation. Additionally, these mutants also show defects in smooth 
muscle formation in the pulmonary vasculature leading to rupture of major vessels or 
hemorrhage and death at birth (Shu et al., 2002). Wnt2 and Wnt2b mutants show a complete 
absence of lung specification. Wnt2 mutants alone, unlike Wnt7b mutants show defects in 
differentiation of the airway smooth muscle but not vascular smooth muscle (Goss et al., 2011). 
Mesenchyme specific loss of β-catenin leads to reduced branching and partial right isomerism. 
Reduced branching in these mutants is due to decreased Fgf10 expression and decreased Fgf10 
signaling in the epithelium. Loss of β-catenin in the mesenchyme also affects the amplification 
of the para bronchial SMCs and the differentiation of the ECs (De Langhe et al., 2008). 
Additionally treatment of in vitro lung cultures with Dikkopf1 (Dkk-1) an inhibitor of canonical 
Wnt signaling, impairs branching due to enlarged terminal buds, decreased αSMA expression 





al., 2005).  Targeted disruption of Wnt5a results in excess branching due to increased Fgf10 
expression and decreased Shh expression (Li et al., 2002). Conversely overexpression of Wnt5a 
leads to reduced branching and dilated distal airways (Li et al., 2005). 
Shh signaling in lung branching 
Shh and different components of the Shh signaling pathway play an essential role in lung 
development and branching (Rutter and Post, 2005).  Shh null mutant mice have a rudimentary 
lung sac due to complete absence of branching and delocalized Fgf10 expression throughout the 
branching tip instead of just the distal tips (Pepicelli et al., 1998).  Additionally, conditional 
inactivation of Shh in lung epithelial cells leads to the formation of hypoplastic lungs with 
reduced branching of the peripheral tubules (Miller et al., 2004).  Hip1 null mutants show a lack 
of secondary branching in the right lobe and subsequently show reduced airway branching and 
increased mesenchyme.  In addition, these mutants show increased Hh signaling and show a 
decrease in the expression of Fgf10 at the distal tips.  This phenotype can be partially rescued by 
removing one allele of Patched (Ptc), the receptor for Hh signaling (Chuang et al., 2003). Gli1, 
Gli2 and Gli3 are target proteins of the Shh signaling pathway.  Gli1 null mice are viable, Gli3 
null mice have smaller lungs with a reduction in lung width, Gli2 null mice have hypoplastic 
lungs with a single lobe in the right lung.   Gli1;Gli2 double null embryos have lungs that are 
smaller than Gli2 null mutant embryos.  The Gli2;Gli3 double null mice fail to show any lung 
formation.  Shh;Gli3 double null mice have a pulmonary phenotype that is less severe than the 
Shh null mutant mice alone. The levels of a truncated repressor form of Gli3 (Gli3R), are much 





 lungs can thus be explained as in the double nulls, the Gli3R level would no longer 





Extracellular matrix in lung branching 
Laminin is a large trimeric glycoprotein that is a major component of basement membranes. 
Addition of anti-laminin antibodies to embryonic lung cultures markedly diminishes tube 
formation and terminal branching as well as mitosis, in epithelial cells (McGowan, 1992). Lungs 
from mice lacking the integrin α3 subunit fail to branch into smaller bronchioles.  Deleting both 
integrin α3 and α6 subunits results in marked lung hypoplasia.  Integrin α8 null mice develop 
fusion of the medial and caudal lobes of the right lung as well as subtle abnormalities in airway 
division. Additionally, specific ablation of the nidogen binding site in the laminin γ1 chain 
causes abnormal lung development. In vitro organ culture suggests a role for fibronectin in 
mediating lung branching morphogenesis (Pozzi and Zent, 2011). A monoclonal antibody 
directed against E-cadherin impairs tube formation and branching in embryonic mouse lung 
organ cultures (McGowan, 1992).  
Heparan sulfate proteoglycans play a crucial role in lung development.  As discussed 
previously, Fgf10 signaling is absolutely essential for lung branching morphogenesis. Fgf10 
interactions with its receptor Fgfr2 are highly dependent on the presence of heparin sulphate 
(HS) proteoglycans, the position of sulfation (O or N) and the degree of sulfation. Disturbing the 
sulfation pattern results in alterations in lung branching patterns and gene expression in vitro 
(Izvolsky et al., 2003b) which cannot be rescued using exogenous excess Fgf10 (Izvolsky et al., 
2003a). 
Development of the trachea 
The dorsal and ventral aspects of the foregut differentiate into esophagus and trachea 
respectively.  The point of fusion of the elongating lung buds is thought to be the origin of the 





esophagus by a septum called the tracheoesophageal septum.  Initially forerunners of the septum 
appear in the lateral walls of the foregut, the so-called lateral ridges, which then fuse in the 
midline.  This process of fusion starts caudally, moves cranially and ends in the region of the 
pharynx.  Recent evidence in the chick argues against the presence of the tracheoesophageal 
septum due to absence of any signs of lateral ridges or of fusion of lateral wall components. The 
alternate hypothesis is that the trachea arises on the floor of an undivided foregut chamber that is 
first seen after the formation of the liver diverticulum caudally and the pharyngeal pouches 
cranially. This chamber becomes smaller as the larynx folds, the lung anlage and the esophagus 
appears, followed by the appearance of the trachea anlage. The trachea elongates by caudal 
growth probably along with the cranial movement of the tracheoesophageal fold (Metzger et al., 
2011).     
Failure of separation of the trachea and the esophagus leads to a condition called 
tracheoesophagal fistula (TEF).   Recent studies suggest patterning of the foregut endoderm 
along the dorsal/ventral axis is marked by greater Sox2 expression dorsally in the future 
esophagus while Nkx2.1 expression marks the future trachea ventrally (Domyan et al., 2011).  
This patterning in turn depends on signals from the surrounding mesenchyme including Fgfs, 
Wnts and Bmps. In the mouse, deficiency of Noggin, Bmp receptor (Bmpr) 1 and Bmpr2,  Shh, 
Gli2 and Gli3, Foxf1  and Sox2 leads to TEF (Litingtung et al., 1998; Motoyama et al., 1998; 
Mahlapuu et al., 2001; Que et al., 2007; Shaw-Smith, 2010; Domyan et al., 2011).  In humans, 
single gene mutations in SOX2 and GLI3 are associated with TEF (Scott, 2009). 
After E11.5, mesenchyme surrounding the dorsal aspect of the trachea differentiates into 
the trachealis smooth muscle.  Mesenchyme surrounding the ventral aspect of the trachea and 





shaped rings composed of chondrocytes.  Defects in smooth muscle or cartilage formation in the 
trachea result in tracheomalacia – lack of rigidity in the trachea and tracheal stenosis – narrowing 
of the trachea (Chen and Holinger, 1994).  Additionally in human patients with Apert syndrome 
the trachea is characterized by a continuous sleeve of cartilage (Moloney et al., 1996).  Ventral 
tracheal cartilage is formed by migration of cells that undergo mesenchymal condensations, 
resulting in an increase in the number of cells per unit area without an increase in cell volume 
(DeLise et al., 2000). Sox9 is as an important regulator of mesenchymal condensations and 
chondrocyte differentiation (de Crombrugghe et al., 2001; Akiyama et al., 2002).  In chondrocyte 
cell aggregate cultures it has been shown that in addition to Sox9, FGF2, Igf1, Tgf2 and Bmp2 
enhance the process of chondrocyte formation (DeLise et al., 2000; Hardingham et al., 2006).  
Mutations in a number of genes including Shh, Sox2, retinoic acid synthesis genes and Fgf 
signaling pathway genes affect cartilage ring formation (Mendelsohn et al., 1994; Pepicelli et al., 
1998; Vermot et al., 2003; Miller et al., 2004; Que et al., 2009; Tiozzo et al., 2009; Park et al., 
2010).  Mutation in Fgfr2c produces a similar phenotype in mice and has been used as a model 
for Apert syndrome (Tiozzo et al., 2009). 
Fgf10 mutants form a partial tracheal tube in spite of the failure of lung formation (Min et 
al., 1998; Sekine et al., 1999).  Recent evidence shows that loss of Fgf10 leads to defects in 
tracheal ring formation and that overexpression of Fgf10 only between E11.5 and E13.5 disrupts 
tracheal rings by altering the periodic expression of Shh in the trachea (Sala et al., 2011). 
Known role of T-box genes in development of the lung and trachea 
All Tbx2 subfamily genes, Tbx2, Tbx3, Tbx4 and Tbx5 are expressed in the developing chick 
lung buds and trachea between stages 15-21 (Gibson-Brown et al., 1998).  In the mouse, Tbx1 is 





at E11.5 and Tbx4 and Tbx5 are expressed in both the lung and trachea mesenchyme at E12.5 
and later (Chapman et al., 1996), although their role in the development of the respiratory system 
is largely unknown.  Tbx1 homozygous null mutants die at birth due to severe heart defects and 
the lungs are never fully inflated (Jerome and Papaioannou, 2001) but lung development has not 
been further investigated.   In Tbx4 homozygous mutants, lung buds form but the embryos die at 
E10.5 due to failure of allantois development and the subsequent lack of chorio-allantoic fusion 
leading to placental insufficiency (Naiche and Papaioannou, 2003).  Tbx5 mutants die around 
E10 due to defects in heart development (Bruneau et al., 2001); lung development has not been 
investigated.  Antisense oligonucleotide depletion of both Tbx4 and Tbx5, but not Tbx2 and 
Tbx3, in lung organ cultures results in inhibition of branching and loss of Fgf10 expression 
(Cebra-Thomas et al., 2003) suggesting a role for these T-box transcription factors in lung 
branching.  In the chick embryo, interference with Tbx4 function leads to a reduction in Fgf10 
expression in lung mesenchyme and inhibits lung bud formation (Figure 1.5).  Ectopic 
expression of Tbx4 leads to ectopic expression of Fgf10 and Nkx2.1 and ectopic lung bud 
formation in the esophagus.  Additionally, ectopic expression of Tbx4 at the boundary between 
the trachea and the esophagus can lead to lack of separation of these two structures, resulting in a 
TEF (Sakiyama et al., 2003).  In humans, Tbx5 mutations lead to Holt Oram syndrome 
characterized by heart and forelimb abnormalities.  Amongst Holt Oram patients, a single de-
novo mutation has been linked to right lung agenesis (Tseng et al., 2007).  No known mutations 
in Tbx4 have been shown to be associated with lung defects in humans.   
Although conditional alleles for Tbx4 and Tbx5 are available in mice (Rallis et al., 2003; 
Naiche and Papaioannou, 2007b), a role for these genes in vivo in the development of the 






Figure 1.1 Phylogenetic tree of T-box genes of zebrafish, Xenopus, chicken, mouse and 





(Hs), Mus musculus (Mm), Xenopus Laevis (Xl), Gallus gallus (Gg), and Danio rerio (Dr); of the 
Drosophila melanogaster gene omb; and of Caenorhabditis elegans tbx11 were used to generate 
a phylogenetic tree. The five subfamilies are delineated by brackets to the right. Cetbx11 was 
outgrouped to root the tree. The following sequences were excluded from the tree due to 









Figure 1.2 Diagrammatic representation of the developing mouse embryo from the bud stage to the 22-26 somite stage 
highlighting the development of the allantois and its vasculature.  The age in embryonic days and the stage of development are 
indicated across the top as are the developmental processes taking place in the allantois. The allantois first appears as a mesodermal 
bud emerging from the posterior end of the primitive streak at E7.5.  The bud grows and expands across the exocoelomic cavity and 
fuses with the chorion to form the chorioallantoic placenta.  The processes in allantois vessel development at each stage are indicated 
across the bottom of the figure.  ECs differentiate and migrate to form a primary vascular plexus.  The plexus connects with the dorsal 







artery and the umbilical vein form at E9.5.  After chorio-allantoic fusion, the allantoic vessels invade the chorion and form the fetal 
vascular component of the labyrinthine layer of the placenta.  epc, ectoplacental cone; exc, exocoelomic cavity; m, mesothelium; c, 









Figure 1.3 Diagrammatic representation of vasculogenesis. Endothelial cell (EC) precursors called angioblasts form by de novo 
differentiation of mesenchyme.  These ECs migrate through the extracellular matrix to first aggregate and then to extend and form 
endothelial tubes.  Endothelial tubes secrete signaling molecules to promote the differentiation of mural cells from the surrounding 
mesenchyme.  Mural cells are recruited to the interconnecting endothelial tubes also called the primary vascular plexus.  The primary 








Figure 1.4 Three methods for allantois culture.  Allantoises can be dissected from embryos from the HF to 4 somite stage, allowed 
to attach to glass, plastic or filters for adherent cultures (top row), or they can be kept in suspension in rolling cultures (middle row) or 
hanging drops (bottom row).  The asterisk indicates the proximal end of the allantois, closest to the embryo.  In adherent cultures the 
distal tip of the allantois attaches to the dish within 6 hours and a vascular plexus forms after 24 hours of culture as indicated by 
staining with Flk1.  Rolling cultures result in development of spheroids with 3 dimensional (3D) morphology, which can be stained 
whole mount as shown for VCAM (Downs et al., 2001).  Hanging drop cultures of allantoises also form 3D structures with a vascular 
plexus after 18 hours of culture.  Image shows fluorescent staining of a whole mount allantois spheroid with α-SMA (red) and Pecam 
(green).  After treatment with VEGF, the ball of vascular plexus remodels into a single layer of Pecam-positive ECs surrounded by α-









Figure 1.5 Signaling pathways involved in primary lung budding. Foregut mesoderm is shown in gray, endoderm in blue, and the 
endoderm of the prospective trachea and lung in red. Lung budding (red) results from mesodermal induction of Fgf10 and from 
activation of Fgfr2b signaling in the endoderm (indicated by a yellow bracket). Retinoic acid (RA) and Tbx genes (TBX4 in chicks) 
regulate Fgf10 expression.  Wnt2 and Wnt2b expressed in the mesenchyme are required for lung/trachea specification.  Gli2 and Gli3 
are both required for primary lung bud formation. Bmp4 is expressed in the ventral mesoderm at the lung field {Modified from 








Table 1.1 Human syndromes caused by mutations in specific T-box genes and their respective mouse mutant phenotypes {Modified from 








TBX1 ; Tbx1   DiGeorge, craniofacial, 
glandular, vascular and heart 
abnormalities 
Viable; thymus and vascular 
abnormalities 
Neonatal lethal; craniofacial, 
glandular, vascular and heart 
abnormalities 
TBX3 ; Tbx3  Ulnar-mammary: hypoplastic 
mammary glands, abnormal 
external genitalia, limb 
abnormalities 
Hypoplastic mammary glands, 
abnormal external genitalia 
Embryonic lethal, yolk sac, 
limb, heart and mammary 
gland defects 
TBX4 ; Tbx4  Small Patella Reduced allantois growth rate Embryonic lethal, allantois 
and limb defects 
TBX5 ; Tbx5  Holt-Oram: heart and hand 
abnormalities 
Heart abnormalities, reduced 
viability 
Embryonic lethal, severe heart 
malformations 
TBX19 ; Tbx19   Recessive isolated ACTH 
deficiency 
Normal ACTH deficiency, pigment 
defects 
TBX22 ; Tbx22  X-linked cleft palate with 
ankyloglossia 
Normal Post natal lethal; submucosal 








Table 1.2 Gene expression related to blood vessel formation and corresponding mutant phenotype in the allantois or placenta  
Category Gene name Expression in the allantois or placenta Phenotype in allantois or placenta 
  Age Area of expression  
Vegf signaling VEGF 5-9s,  E12.5  Mt, labyrinthine stromal 
cells  
Degenerating endothelium in 
placenta 
Flk1 E7.5, 9-16s, E12.5  EC, placental vasculature Lack of mature ECs in the 
allantois 
Flt1 9-16s, E12.5  EC, placental vasculature Nd 
EC Pecam E8.0 onwards EC None (viable) 
VE-Cadherin E8.0 onwards EC No allantois plexus 
Hematopoietic Tal1 E7.0-8.0 EPC Absence of blood  
Runx1 E8.0-8.5 Hematopoietic 
precursors 
Nd 
SMC SM22α E8.25 SMC None (viable) 
αSMA E8.25 SMC Nd 
ECM Fibronectin E8.25 Mes Nd 
Itgα5 E8.25 Mes Nd 
Collagenα1(I) E8.25 Mes Nd 
Has2 E8.25 Mes Nd 
Vcan E8.25 Mes Nd 




Np1  Nd Nd 
Np2  Nd Nd 
Tie1 9-16s, E12.5  EC, placental vasculature Nd 
Tie2 9-16s, E12.5  EC, placental vasculature Nd 
Ang1 Nd Nd Lack of complexity in umbilical 
vessels 
Ang2 Nd Nd Nd 
TGFβ E7.5-8.5 Nd Defective chorio-allantoic fusion, 
lack of Flk1 expression in allantois 
Alk1 Nd Nd Nd 
Alk5 Nd EC & SMC of placenta Defective sprouting of the allantois 
into the placenta, lack of SMCs 






























CAP, chorio-allantoic placenta; EC, EC; ECM, extracellular matrix; EPC, endothelial precursor cells;  
Mt, mesothelium; Mes, mesenchyme; Nd, not defined, SMC, smooth muscle cell; UA, umbilical artery; UV, umbilical vein. 
  
Artery vs Vein ephrinB2 E9.5 Vascular plexus, UA None 
EphrinB4 E9.0 EC/UV Nd 
Notch2 E8.25 Mes Nd 
Dll4 E8.25 Arterial EC Degenerating vasculature in 
placenta 









Wnt2 E8.0-9.5 Mes Late gestation hemorrhage and 
tissue disruption in placenta 
Wnt5a E7.0,8.0 Mes No affect on allantois 
Wnt11 E7.0-8.0 Mes Nd 
Rspo3 E8.0, 8.5 mes Vessels fail to invade placenta 
Bmp4 E8.25 Mes Small or no allantois 





E7.5, E8.25 Mes Lack of EC formation 
Foxf1 E8.25 Mes Absence of vasculature in allantois 
Snai1 E8.25 Mes ECs fail to form plexus 
dHAND E8.25 Mes Nd 
T E7.5-E8.5 Mes  ECs fail to form plexus, lack of  
chorio-allantoic fusion 











Table 1.3 Gene function identified using allantois culture as a model system 
 











(null mutant and 
VE-Cad Ab) 
Disconnected ECs in 
plexus 
EC motility; addition of 
ECs to new sprouts; 
plexus stabilization 
VE-PTP Phosphatase LOF 
(null mutant) 
Excess EC coverage and 
simple monolayer 
architecture of ECs 
Remodeling of plexus to 
provide complexity 










(added to culture) 
Promotes plexus formation 
in serum-deprived cultures 
Promotes vasculogenesis 












(added to culture) 
Prevents allantois culture 





PI3K Kinase LOF 
(inhibitor) 
Decrease in sprout 
formation 
Angiogenesis 
Arap3 GTPase LOF 
(null mutant) 
Decrease in sprout 
formation 
Angiogenesis 
 RA-GEF1 GTPase LOF 
(null mutant) 
Decrease in sprout 
formation 
Controls activation of 
RAP1 and induction of 
VE-Cad 
 PDGFBB Growth 
factor 
GOF 
(GF in culture) 
Promotes plexus formation 
in low serum conditions 
EC survival or 
maintenance 
 HDAC Deacetylase LOF 
(inhibitor) 
Decrease in ECs Increased commitment  
of progenitors to ECs 
 Bmp4 Signaling LOF 
(inhibitor) 
Decrease in plexus 
formation 
Recruitment of mural 
cells that promote plexus 
stabilty 





Chapter 2.  Canonical Wnt signaling acts downstream of Tbx4 in 
development of the allantois vasculature and the chorio-allantoic 
placenta 
Introduction 
Mutation of the T-box transcription factor gene Tbx4 results in abnormal vascular development 
in the allantois, loss of cavitation, apoptosis and lack of chorio-allantoic fusion leading to 
embryonic death at E10.5 (Naiche and Papaioannou, 2003).  Tbx2, another T-box gene expressed 
in the allantois and Vcam, a cell adhesion molecule are absent while Bmp4 expression is 
unaffected in Tbx4 mutant allantoises.  Pecam, a marker of ECs, is abundantly expressed in cells 
of Tbx4 mutant allantoises but these ECs do not coalesce into a primary vascular plexus (Naiche 
and Papaioannou, 2003).  Comparison of Tbx4 RNA and Pecam protein localization as well as 
lineage tracing using a Tbx4-cre allele suggest that the ECs of the umbilical vessels do not and 
never have expressed Tbx4 (Naiche et al., 2011).  In spite of this, Tbx4 null mutants show a 
defect in allantois EC organization suggesting that Tbx4 plays a non-cell-autonomous role in 
formation of the vascular plexus.  We took a candidate gene approach to find Tbx4 target genes 
expressed in the mesenchyme that could explain this non-cell-autonomous effect.   
Materials and methods 
Mice 
Mice carrying a Tbx4 null allele, Tbx4
tm1.2Pa
 (Naiche and Papaioannou, 2003), hereafter referred 
to as Tbx4
-
, a Wnt2 null allele, Wnt2
tm1.1(rtTA)Eem
 (Goss et al., 2009), hereafter referred to as Wnt2
-
, 
a Tbx4-cre allele, an insertion into the endogenous Tbx4 locus resulting in a bicistronic allele that 





(Naiche et al., 2011) and a β-catenin conditional allele (Brault et al., 2001), hereafter referred to 
as βcatenincond, were genotyped as described previously.  
Histology and vessel counts in the chorio-allantoic plate  
Embryos and placentas were collected from timed matings and dissected out of the decidua; yolk 
sacs were removed for genotyping and the placentas were fixed in Bouin’s fixative (Sigma).  
After dehydration in ethanol, placentas were embedded in paraffin wax, sectioned at 10 µm and 
stained with hematoxylin and eosin (H&E).  From cross sections through the center of the 
placenta, every 5
th
 section (for a total of 15-20 sections/placenta) was used to quantitate 
vasculature by counting the number of vessels per section present in the chorio-allantoic plate 
(CAP).  The total number of vessels per placenta was used as a representation of amount of 
vasculature in the CAP. Three to five placentas were analyzed for each genotype. 
In situ hybridization and immunohistochemistry  
Whole-mount in situ hybridization (ISH) and immunohistochemistry (IHC) were performed 
according to standard protocols (Davis, 1993; Wilkinson and Nieto, 1993).  Primary antibodies 
used include anti-Flk1 (R&D), anti-Jag1 (R&D) and anti-Fibronectin (SCBT); secondary 
antibodies were peroxidase-conjugated and Cy3-conjugated donkey IgG (Jackson 
Immunochemicals). For each ISH or IHC, 2 to 7 mutant embryos were analyzed. 
Ex vivo allantois culture 
Allantoises were dissected from embryos at different stages in DMEM-Hepes (Invitrogen) with 
5% FBS and transferred to 24 well dishes containing 0.5 ml of rat serum (Pel-Freeze Biologicals) 
and DMEM (Invitrogen) in a 1:1 ratio.  For rescue experiments, lithium chloride (LiCl) was 





make Wnt2 conditioned media and vector-transfected CHO cells were used to make control 
conditioned media (Klein et al., 2008).   For conditioned media rescue experiments, allantoises 
were cultured in 50% rat serum, 25% control or Wnt2-conditioned media and 25% DMEM.  For 
inhibition of canonical Wnt signaling, 100 µM IWR1 (Cayman Chemicals) prepared in DMSO 
or DMSO alone was added to cultures and allantoises were cultured for 36-40 hours.  For 
antibody staining, the cultures were fixed overnight in 4% PFA, washed in PBS with 0.5% 
Triton, and treated for IHC for Flk1. For each experiment n was ≥2. 
Results  
Tbx4 mutant allantoises fail to form a vascular plexus ex vivo 
To investigate their vessel forming potential, Tbx4 mutant and control allantoises were cultured 
ex vivo for 24 hours starting from the HF stage to the 6 somite stage.  Wild-type or Tbx4 
heterozygous allantoises from the earliest stages give rise to clusters of ECs, whereas explants 
from later stages spread out and give rise to a network of interconnected ETs or a plexus (Downs 
et al., 2001; Crosby et al., 2005), as shown by Flk1 antibody staining (Figure 2.1A-F).  Tbx4 
mutant allantoises, on the other hand, had clusters of ECs or ETs but failed to form a vascular 
plexus of interconnected ETs even from the later explants (Figure 2.1G-I).  Methylene blue 
staining for cells other than ECs in allantois cultures (Figure 2.1B,E,H) shows the extent of 
allantois outgrowth. The proportion of explants of each genotype that proceeded to form EC 
clusters, ETs or a vascular plexus is shown in Figure 2.1J.  Since, Tbx4 mutant allantoises show 
increased apoptosis (Naiche and Papaioannou, 2003), we tested if decreased cell numbers 
affected plexus formation.  Control allantoises isolated at 2-4 somites when split in half still 
formed a vascular plexus upon culture, although the plexus was smaller than that from whole 





Tbx4 mutants.  As Tbx4 is not expressed in ECs of the allantois and cells derived from Tbx4 
expressing cells never contribute to the endothelium of the umbilical vessels (Naiche et al., 
2011), these data suggest that Tbx4 plays a non-cell-autonomous role in the development of 
allantois vasculature.  Thus, Tbx4 could either regulate the developing mesenchyme surrounding 
the ECs or the ECM through which the ECs migrate in order to form ETs and a primary plexus. 
Tbx4 is upstream of ECM molecules, signaling molecules and transcription factors  
In order to explore the role of Tbx4 in the development of the allantois we took a candidate gene 
approach and analyzed the expression of various ECM markers, signaling molecules and 
transcription factors.   Candidates were chosen if their loss either leads to chorio-allantoic fusion 
defects or results in an embryonic vascular phenotype similar to the Tbx4 mutant allantois 
vascular phenotype. 
To examine specific components of the ECM that might be affected in Tbx4 mutant 
allantoises, we analyzed expression of Versican (Vcan), a chondroitin sulphate proteoglycan and 
a binding partner for hyaluronic acid (HA) (Yamamura et al., 1997); and Hyaluronic acid 
synthase2 (Has2) (Camenisch et al., 2000) because HA is involved in the process of allantois 
cavitation (Fenderson et al., 1993) which is disrupted in Tbx4 mutants (Naiche and Papaioannou, 
2003).  Both Vcan and Has2 were expressed in wild-type allantoises but were absent from Tbx4 
mutants (Figure 2.2A,B).  We also analyzed the expression of α5 integrin (Itgα5) and 
Fibronectin (Fn), ECM genes known to be essential for vascular development.  EBs lacking 
either of these components form Pecam-positive ECs but fail to form ETs (Francis et al., 2002).  
Expression of Itgα5 was absent (Figure 2.2C) whereas Fn and Collagen αI (1) (Colα1(I)) were 





Bmp signaling is important for allantois development specifically for the process of 
chorio-allantoic fusion and this process is affected in  Bmp2 mutants (Zhang and Bradley, 1996) 
and double mutants for Bmp7 and Bmp5 (Solloway and Robertson, 1999).  Expression of both 
Bmp2 and Bmp7 was absent in Tbx4 mutant allantoises (Figure 2.2F,G).  Wnt2, one of the 
canonical Wnt family members, is expressed in the allantois and Wnt2 mutants show placental 
defects (Monkley et al., 1996).  Wnt2 is expressed throughout the process of growth and 
vascularization of the allantois starting at the LHF stage (Monkley et al., 1996). Wnt2 expression 
was absent in Tbx4 mutant allantoises (Figure 2.2H).  On the other hand, non-canonical Wnt5a 
was expressed normally in mutant allantoises (Figure 2.2I).  Notch signaling components Notch2 
(Hamada et al., 1999) and Delta like 4 (Dll4) (Gale et al., 2004) are expressed in the vasculature 
of the placenta and mutations in these genes result in a poorly-vascularized allantois and 
labyrinth.   Mutation in  Jagged1 (Jag1), one of the ligands for Notch receptors, leads to yolk sac 
and embryonic vasculature defects (Xue et al., 1999), but the allantois and placenta have not 
been analyzed in these mutants.  Dll4 was expressed in the mutant allantoises but Dll4-positive 
ECs formed clusters and failed to form vessels (Figure 2.2J).  Jag1 was expressed in control 
allantoises but this expression was absent in Tbx4 mutant allantoises (Figure 2.2K).  Similarly, 
Notch2 (Figure 2.2L) was not detected in Tbx4 mutant allantoises.   
Epiblast-specific deletion of transcription factor Snai1 leads to a vascular phenotype in 
which the ECs of the embryo and the allantois express Pecam but fail to coalesce to form ETs 
(Lomeli et al., 2009) similar to Tbx4 mutant allantoises.  Twist, another transcription factor, has 
been shown to be important for Snai1 expression (Leptin, 1991). Both Snai1 and Twist 





Agonists of the canonical Wnt signaling pathway rescue and an antagonist 
phenocopies the Tbx4 mutant phenotype ex vivo 
Wnt2, the canonical Wnt known to be expressed in the allantois was absent in Tbx4 mutant 
allantoises.  Therefore, we examined the contribution of the canonical Wnt pathway to the 
vessel-forming potential of the allantois under the control of Tbx4. 
The canonical Wnt signaling pathway was activated in culture using LiCl, an inhibitor of 
GSK3-β and thus an activator of β-catenin-mediated transcription (Rao et al., 2005).  When 
treated with LiCl, Tbx4 mutant allantois explants formed ETs which interconnected and formed a 
vascular plexus ex vivo (Figure 2.3B) unlike mutant allantoises cultured in the absence of LiCl, 
which never formed a vascular plexus (Figure 2.3A).  The total number of interconnections of 
the ETs in the vascular network was compared in rescued and control mutant allantoises as a 
measure of the extent of plexus formation (Figure 2.3C).  The number of interconnections as 
shown by notched box plots was significantly different between control and LiCl treated mutants 
(Mann Whitney U test p=0.0016) (McGill et al., 1978).  Similar rescue of ET and plexus 
formation was seen when Wnt2 conditioned media was added to the mutant allantois cultures 
(control mutants, n=2, values 1, 10; mutants with Wnt2 conditioned media, n=2, values 54, 63) 
(Figure 2.3D, E). 
IWR1 a small molecule inhibitor was used to block the canonical Wnt signaling pathway 
at a concentration found to be non-toxic to cells in organ culture (Karner et al., 2010).  
Allantoises from wildtype embryos were isolated at EHF-LHF (Figure 2.3F,G,H) and LHF-1 
somite stages (Figure 2.3I,J,K) and IWR1 in DMSO or DMSO alone was added to the cultures.  
In the presence of inhibitor, wildtype allantoises failed to form a vascular plexus but showed 





Wnt signaling contributes to the vessel forming ability of allantoises ex vivo, and in the absence 
of this signal the ECs fail to form a primary vascular plexus. 
Tbx4 and Wnt2 genetically interact during the formation of the chorio-allantoic 
placenta  
Since canonical Wnt signaling is necessary for formation of allantois vessels ex vivo we tested 
whether Tbx4 mediated control of canonical Wnt signaling alone was responsible for vessel 
formation in allantoises in vivo.  Wnt2 is the only known canonical Wnt expressed in the 








 allantoises.  Allantoises from 
both these genotypes fused with the chorion normally at E8.5 and formed normal umbilical 
vessels at E10.5 indicating no genetic interactions between Tbx4 and Wnt2 during allantois 




allantoises could be due to activation of β-catenin by another pathway.  Thus, in order to create a 
mesenchymal deletion of β-catenin, we used a Tbx4-cre (Naiche et al., 2011) and a β-catenin 
conditional allele (Brault et al., 2001).  Tbx4
cre/+; βcatenincond/cond embryos did not show an 
allantoic vascular phenotype. 




 embryos was analyzed later in 
development.  At E11.5, there is a decreased amount of perivascular stroma in the chorio-
allantoic plate (CAP) of double heterozygous placentas (Figure 2.4A-D).  The extent of 
vascularization of the CAP was analyzed using H & E sections of controls and double 
heterozygote placentas (Figure 2.4A,B).  Quantification of the vessels shows a significantly 
lower number of vessels present in double heterozygotes compared to controls (Mann Whitney U 
test p=0.001).  At E13.5, double heterozygotes showed interdigitation of the spongiotrophoblast 





the labyrinthine layer as seen by the ratio of area of labyrinth to the combined area of labyrinth 
and spongiotrophoblast in double heterozygotes (Figure 2.4I, Mann Whitney U test p=0.002).    
Discussion 
Tbx4 affects multiple processes important for allantois development including chorio-allantoic 
fusion, cavitation, cell proliferation and vasculogenesis (Naiche and Papaioannou, 2003).  Here 
we show evidence that Tbx4 acts as a regulator of all these processes by regulating expression of 
a variety of genes including ECM genes, signaling molecules and transcription factor genes 
either directly or indirectly.  We show that expression of ECM molecules Versican, Has2, Itgα5, 
transcription factors Snai1 and Twist and signaling molecules Bmp2, Notch2 and Wnt2, was 
absent in the Tbx4 mutant allantoises.  Individual mutations in some of the genes identified 
downstream of Tbx4 are enough by themselves to explain the EC phenotype of the mutant 
allantoises.  For example, Snai1 epiblast-specific mutant allantoises are incapable of forming a 
vascular plexus in the embryo proper and in the allantois explants, although they show the 
presence of differentiated Pecam-positive ECs (Lomeli et al., 2009) and Snai1 is absent in Tbx4 
mutant allantoises. Itgα5 (Francis et al., 2002) and Wnt2 mutant EBs (Wang et al., 2007) that are 
differentiated down the vascular pathway show Pecam-positive ECs but do not form a vascular 
plexus and both these genes are not detected in the Tbx4 mutant allantoises.  
Four of the genes absent in Tbx4 mutant allantoises, Vcan, Jag1, Snai1 and Twist, are 
downstream targets of the canonical Wnt signaling pathway in different systems 
(http://www.stanford.edu/group/nusselab/cgi-bin/Wnt/target_genes) indicating a role for 
canonical Wnt signaling in development of allantois vasculature downstream of Tbx4.   
Additionally, since Tbx4 is not expressed in ECs of the allantois but still causes a drastic effect 





a non-cell-autonomous effect.  In addition, Wnt2 a canonical Wnt known to be expressed in the 
allantois, was absent in Tbx4 mutants. There is evidence that Wnt2 plays an important role in EC 
proliferation and network formation specifically in hepatic sinusoidal ECs (HSEC’s). Wnt 
inhibitors lead to reduced proliferation and reduced endothelial tube forming ability of HSEC’s 
on matrigel (Klein et al., 2008). Additionally, Wnt2 null EBs fail to form a Pecam-positive 
vascular plexus and the vessel forming ability could be rescued by the exogenous addition of 
Wnt2 conditioned media (Wang et al., 2007). We were able to rescue the vessel-forming 
potential of the Tbx4 mutant allantoises by activating the Wnt signaling pathway using LiCl and 
by adding Wnt2 conditioned media. We were also able to phenocopy the mutant phenotype by 
addition of a tankyrase inhibitor IWR1.  Tankyrase destabilizes axin and prevents β-catenin from 
degradation, thus in the presence of the inhibitor β-catenin is degraded, blocking the canonical 
Wnt signaling pathway (Karner et al., 2010).  Taken together, our results suggest that canonical 
Wnt signaling contributes to the vessel forming ability of allantoises ex vivo, and in the absence 
of this signal the ECs fail to form a primary vascular plexus. 
Tbx4 and Wnt2 did not show interactions during allantoic vessel formation in vivo.  One 
possible explanation for the lack of genetic interaction is that other, as yet unknown, canonical 
Wnts are expressed in the allantois.  Alternatively, β-catenin could be activated downstream of 








 allantoises.  It 
has already been shown that conditional excision of β-catenin in ECs does not affect allantois 
vascular development (Cattelino et al., 2003).    Thus, neither an endothelial, nor a mesenchymal 
deletion of β-catenin (our study) reproduces the Tbx4 mutant phenotype, indicating that possibly 
pathways other than canonical Wnt signaling that are regulated by Tbx4 play a role in 





phenotype in the allantoises of Tbx4
cre/+; βcatenincond/cond embryos is due to delayed or 
incomplete excision of β-catenin in the allantois mesenchyme with the Tbx4cre.  There is a lag in 
reporter gene expression when using the Tbx4-cre as compared to Tbx4 expression (Naiche et al., 
2011).  Since the process of allantois development from the appearance of bud to chorio-
allantoic fusion occurs in a short span of about 12 hours, the deletion of β-catenin may not occur 
soon enough to see a phenotype prior to chorio-allantoic fusion.  Brachyury
cre
 is another 
mesodermal cre that can excise β-catenin early in development, but excision of β-catenin in the 
primitive streak, where Brachyury is also expressed, can produce streak related phenotypes that 
will overshadow an allantoic phenotype.   
We show that although Tbx4 and Wnt2 do not interact in allantois vascular network 
formation in vivo, they interact during the formation of the fetal labyrinthine layer.  Wnt2 by 
itself is important for the proper formation of the different placental layers and Wnt2 null 
mutants show disruptions in the placental labyrinthine layer (Monkley et al., 1996).  In addition, 
canonical Wnt signaling has been shown to be very important for placenta development; 
deficiency in a number of genes involved in Wnt/β-catenin signaling show mid-gestation 
lethality due to placental insufficiency. For example, conditional inactivation of β-catenin in ECs 
shows a phenotype similar to Wnt2;Tbx4 double heterozygotes, where the labyrinthine layer is 
smaller and less vascularized (Cattelino et al., 2003).  Rspondin3, a secretory molecule whose 
proposed function is to promote the canonical Wnt signaling pathway, is expressed in the 
allantois.  Fetal vessels of Rspo3 null embryos fail to penetrate the chorion leading to lethality 
during mid-gestation (Aoki et al., 2007). Similarly Wnt receptor Fzd5 is expressed in the 
labyrinthine layer and null mutants for Fzd5 die due to lack of penetration of fetal vessels into 





show decreased vascular coverage in the chorioallantoic plate, again suggesting the importance 
of Wnt2 in the vessel forming potential of ECs derived from the allantois. Furthermore, double 
heterozygous placentas show a mixing of placental layers reduced fetal placental layer.  Thus, 
although Wnt2 does not genetically interact with Tbx4 in the process of vessel formation in the 
allantois in vivo, these genes do interact in formation of the vasculature of the CAP and the 

















allantoises isolated from LHF-6 somite stage embryos were cultured for 24 hours, stained with anti-Flk1 antibody and scored for 
formation of isolated EC clusters, ETs or a vascular plexus.  Cultures in B, E, H were counterstained with methylene blue. (J) Stacked 
bar graphs show the relative proportions of allantoises that formed EC clusters, ETs, or a vascular plexus amongst allantoises from 









Figure 2.2 Identification of genes downstream of Tbx4 in the allantois using a candidate 
gene approach and ISH or IHC.  (A-E)  Expression of ECM genes Vcan, Has2 and Itgα5 was 
undetectable whereas Cola1(I) and Fn were unaffected in Tbx4 mutants.  Inset in E shows 
secondary antibody control in the absence of primary antibody against Fn.  (F-L) Expression of 
signaling molecules Bmp2, Bmp7, Wnt2, Jag1, and Notch2 was undetectable; Wnt5a was 
unaffected; Dll4 was expressed in an EC-like pattern in the Tbx4 mutants. (M-N) Expression of 
transcription factors (TF) Snai1 and Twist expression was undetectable in Tbx4 mutant 








Figure 2.3 Wnt signaling is essential for vessel formation in allantoises ex vivo.  (A-B) 
Vascular plexus formation is rescued in Tbx4 mutant allantoises in the presence of 5 mM LiCl.  
(C) Quantification of the number of ET interconnections in the absence and presence of LiCl 
using notched box plots (bars represent standard deviations). When the notches do not overlap, 
the medians are significantly different at ~95% confidence level. (D-E) Wnt2 conditioned media 
but not control conditioned media rescues plexus formation in mutant allantoises.  (F-K) IWR1 
inhibits plexus formation in control allantoises. (H) Quantification of number of ET 
interconnections formed in allantoises cultured starting EHF-LHF with or without IWR1.  (K) 
Quantification of number of ET interconnections formed in allantoises cultured starting LHF-
1som with or without IWR1.  Notched box plots (H,K) show significantly lower number of 
interconnections in the presence of IWR1 (bars represent ranges).  Cultures were stained with 














Figure 2.4 Genetic interactions between Tbx4 and Wnt2 in formation of the chorio-allantoic 
placenta.  (A-B’) Placenta morphology of controls and Tbx4+/-;Wnt2+/- at 11.5.  A’ and B’ are 





CAP.  (C,D) Pecam staining of chorio-allantoic plate at E11.5.  Arrowheads point to vessels.  (E-
F’) At E13.5, interdigitation of spongiotrophoblast, demarcated by dashed lines, and labyrinthine 
layers is observed in double heterozygote placentas, unlike controls.  E’ and F’ are higher 
magnification views of boxed regions in E and F. (G,H) Pecam staining of E13.5 placentas. (I) 
Notched box plots show a significantly lower ratio of area of labyrinth/(area of 
spongiotrophoblast + labyrinth) in the double heterozygotes compared to controls at E13.5 (bars 







Chapter 3.  Multiple Roles and interactions of Tbx4 and Tbx5 in 
development of the respiratory system 
Introduction 
The development of the respiratory system represents an evolutionary hallmark that allowed 
vertebrates to survive on land utilizing air as a source of oxygen.  Because the respiratory system 
is dispensable for embryonic survival in mammals, defects in development of the respiratory 
system manifest at or after birth.  Indeed, abnormal development of the respiratory system in 
humans is associated with multiple disorders including but not limited to tracheal/bronchial 
atresia, TEF, bronchogenic cysts, pulmonary/lobar atresia and pulmonary hypoplasia (Whitsett et 
al., 2004).  Thus, understanding the genetic basis of development of the respiratory system is 
important and this has been largely investigated using the mouse as a model.   
Tbx4 and Tbx5 are the most closely related T-box genes with 94% homology in their T-
box binding domain (Epstein et al., 2008). Although a role for these genes has not been analyzed 
in tissues that coexpress them – lung, trachea and genital tubercle – these genes can substitute for 
each other during limb formation suggesting similar roles in initiation and maintenance of limb 
outgrowth (Minguillon et al., 2005).  Both Tbx4 and Tbx5 are expressed in the mesenchyme of 
the developing lung and trachea and although multiple genes are known to be required in the 
epithelium, only Fgfs have been well studied in the mesenchyme.  Thus, we investigated the 
roles of Tbx4 and Tbx5 in lung and trachea development.  We studied three distinct processes 
important for development of the respiratory system, namely 1) lung bud and trachea 







Materials and methods 
Mouse strains, crosses and embryo collection 
Mice carrying the following alleles were genotyped as previously described: a Tbx4 conditional 
‘floxed’ allele, Tbx4tm1.2Pa (Naiche and Papaioannou, 2007b), hereafter referred to as Tbx4fl; a 
Tbx5 conditional floxed allele, Tbx5
tm1.2Jse 
(Mori et al., 2006), hereafter referred to as Tbx5
fl
; an 
Fgf10 null allele (Min et al., 1998); ROSA26
CRE-ERT2
, a ubiquitous tamoxifen-inducible cre 
transgene (de Luca et al., 2005), hereafter referred to as CreER; Tbx4-cre, an insertion into the 
endogenous Tbx4 allele resulting in a bicistronic allele that expresses both cre and Tbx4 in all 
areas of Tbx4 expression including lung and trachea (Luria et al., 2008; Naiche et al., 2011), 




and a R26RlacZ reporter (Soriano, 1999).  All lines of mice were 
kept on mixed genetic backgrounds.  Embryos were dissected from timed matings and yolk sacs 
were removed for PCR genotyping.  The dark period was 19.00 to 05.00 h and noon on the day a 
mating plug was identified as E0.5.    
Tamoxifen injections 
Tamoxifen (Sigma) at a concentration of 20 mg/ml in sunflower oil (Sigma) was administered to 
pregnant females by intraperitoneal injection between 15.30 and 19.30 hours on E8.5 or between 
23.00 and 24.00 hours on E9.0.   
In situ hybridization, immunohistochemistry and histology 
Whole-mount ISH, immunohistochemistry (IHC) and ISH on cryosections was performed as 
described previously (Davis, 1993; Wilkinson and Nieto, 1993; Grieshammer et al., 2004).  
Primary antibodies used were anti-PECAM (Pharmingen, catalog number 01951D) and anti-E-
cadherin (Takara clone ECCD-2).  All secondary antibodies were peroxidase-conjugated donkey 





For histology embryos were removed from the uterine horns, dissected out of the decidua and the 
embryos were fixed in Bouin’s fixative (Sigma).  After dehydration in ethanol, embryos were 
embedded in paraffin wax, sectioned at 8 µm thickness and stained with hematoxylin and eosin 
(H & E).  
Alcian blue staining 
Alcian blue staining was performed according to standard protocols (Nagy et al., 2009).  Briefly, 
lungs and trachea were dissected out at different stages, fixed in Bouin’s fixative and washed 
with 70% ethanol.  The tissue was then equilibrated in 5% acetic acid and stained with 0.05% 
alcian blue in 5% acetic acid for 2 hours.  The tissue was washed in 5% acetic acid to remove 
excess stain and dehydrated in 100% methanol, cleared in BABB (benzyl alcohol, benzyl 
benzoate) and photographed.  For alcian blue staining on sections, 8 µm paraffin sections were 
rehydrated, treated with 0.05% alcian blue in 5% acetic acid and then counterstained with 
nuclear fast red. 
Foregut and lung bud culture 
Foregut culture was carried out as described previously (Chen et al., 2010).  Briefly, foreguts 
were isolated from 8-16 somite stage embryos using tungsten needles and cultured at 37
o
C in the 
presence of 95% air and 5% CO2 on Transwell-Col filters (Fisher Scientific), containing 1.5 ml 
BGJb media (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 0.2 mg/ml vitamin 
C (Sigma) and 2 µM 4-OH tamoxifen (Sigma).   For lung bud culture, lung buds were dissected 
at E11.5 in phosphate buffered saline (PBS) with 0.1% bovine serum albumin (Sigma) and 
cultured in media containing DMEM (Invitrogen) with 10% fetal bovine serum, 1% 
penicillin/streptomycin (Invitrogen) and 1 µM 4-OH tamoxifen on 3.0 µm filters (Millipore) or 





filter; results reported are for experiments with Millipore filters.  Where specified, Fgf10 (R&D) 
was added after 1 day of culture at a concentration of 500 ng/ml. In some experiments heparin 
beads coated with Fgf10 (100µg/ml) or BSA (100µg/ml) were placed near the branching tips of 
the explants after 1 day of culture. Transwell filters were used for the bead experiments. 
Lung branching analysis 
Lungs were stained with either E-cadherin antibody using IHC or E-cadherin RNA probe using 
ISH. In case of whole mount lungs, different lobes were separated and photographed to count the 
number of branching tips. The cultured lungs were photographed and the branching tips were 
counted. For some experiments, after E-cadherin ISH, lungs were post fixed in 4% PFA, washed 
with PBT, dehydrated in 100% methanol, cleared in BABB and then photographed.  
Results 
Expression of Tbx4 and Tbx5 in the developing lung and trachea  
Tbx5 expression is first detected using in situ hybridization (ISH) at E9.0 (24 somites) in the 
mesenchyme of the lung and trachea primordia, concurrent with Nkx2.1 expression in the ventral 
foregut epithelium (Figure 3.1A,B).  Tbx4 expression is detected in the lung buds when they first 
appear a few hours later at E9.25 (28 somites) in a pattern similar to Tbx5 (Figure 3.1C, D).  
Tbx4 and Tbx5 are expressed at E11.5, E13.5 and E15.5 throughout the lung mesenchyme but 
not the epithelium (Figure 3.1E-J) (Chapman et al., 1996). 
Both Tbx4 and Tbx5 show a dynamic expression pattern in the developing trachea.  At 
E11.5 and E13.5 both genes are expressed throughout the tracheal mesenchyme surrounding the 
epithelium but are excluded from the epithelium and the outermost layer, the mesothelium 
(Figure 3.1E,F,K,K’,L,L’).  At these stages, Tbx4 and Tbx5 are expressed in ventral tracheal cells 





that also express SM22α (Figure 3.1M,M’) (Badri et al., 2008).  Within the ventral mesenchyme 
at E15.5, Tbx4 and Tbx5 expression is restricted to mesenchyme between and surrounding 
cartilage condensations (Figure 3.1O,P) in a pattern complementary to that of Sox9, which is 
restricted to condensing mesenchyme of the cartilage rings at this stage (Figure 3.1Q).  
Efficiency of recombination of conditional alleles 
The genotypes of embryos used in this study and the corresponding descriptive shorthand 
nomenclature are shown in Table 3.1.  In order to determine the efficiency of recombination of 
the conditional alleles by the CreER transgene, we used PCR genotyping.  For embryos carrying 
the CreER transgene, a dose of 8 mg tamoxifen was injected into pregnant females at E9.0 and 
embryos were dissected at E12.5.  Yolk sacs of these embryos were analyzed as an estimate of 
recombination in the whole embryo.  Both alleles of Tbx4
fl/fl
 embryos were completely 
recombined at E12.5 to produce the mutant allele at this dose of tamoxifen (Figure 3.2A), but the 
single floxed allele of Tbx5
fl/+ 
embryos was only partially recombined to the mutant form (Figure 
3.2E). Doses of tamoxifen higher than 8 mg at E9.0 lead to a loss of pregnancy.  When 7 mg 
tamoxifen was injected at E8.5, complete recombination of the Tbx4
fl
 alleles (Figure 3.2B) and 
the single Tbx5
fl
 allele (Figure 3.2F) was obtained at E13.5.   
In lung bud cultures a concentration of 1µM 4-OH tamoxifen produced near-complete 
recombination of the Tbx4
fl
 allele after 24 hours (Figure 3.2C) whereas the Tbx5
fl
 allele was only 





 alleles was achieved after 4 days of culture (Figure 3.2D,H).  These data suggest that 
the Tbx5
fl
 allele has a lower efficiency of Cre-mediated recombination than the Tbx4
fl
 allele.  
Thus we assume that there may be some residual Tbx5 activity from the Tbx5
fl
 allele in the in 







Early loss of Tbx5, but not Tbx4, leads to a unilateral loss of lung bud specification and 
absence of tracheal specification 
To explore the role of Tbx4 and Tbx5 in the earliest stages of lung and trachea specification, 
foregut culture was used (Chen et al., 2010) with Nkx2.1 as a marker of specification.  This ex 
vivo technique allows for analysis of mutants in culture, circumventing early embryonic lethality 
of the Tbx4 homozygous mutants due to allantois defects and Tbx5 homozygous mutants due to 
heart defects. When foreguts and surrounding tissue are isolated at E8.75 (8-16 somites), the 
foregut tube is devoid of Nkx2.1 expression and the lung buds are not present (Harris-Johnson et 
al., 2009). At the end of 3 or 4 days of culture the lung buds and trachea have formed as seen by 
Nkx2.1 expression (Figure 3.3A,D,G). Expression of Tbx4 and Tbx5 was confirmed in control 
foreguts that were cultured for 4 days (Figure 3.3B,C).  Foreguts from E8.5 embryos of various 
Tbx4 and Tbx5 genotypes, with and without the CreER transgene were cultured in the presence 
of 4-hydroxyl (OH) tamoxifen and analyzed for Nkx2.1 expression. Reduction of Tbx5 alone lead 
to a lack of Nkx2.1 expression in one of the lung buds after 3 days of culture (Figure 3.3E) and 4 
days of culture (Figure 3.3H) suggesting a unilateral loss of lung bud specification. Removal of 
Tbx4 alone did not affect Nkx2.1 expression after 3 days of culture and removal of Tbx4 alleles in 
addition to Tbx5 alleles did not exacerbate the Tbx5 phenotype (Figure 3.3F,I).  Therefore, Tbx5 
but not Tbx4 is important for the bilateral specification of lung buds ex vivo. 
With respect to tracheal specification, Nkx2.1 expression was not observed in the foregut 
tube after 3 or 4 days of culture in embryos lacking Tbx5 (arrowheads in Figure 3.3E,H) 
suggesting a lack of tracheal specification in the foregut tube in the absence of Tbx5.  Additional 
loss of Tbx4 alleles did not alter the phenotype (Figure 3.3F,I), supporting a role for Tbx5 in the 





Lung branching is severely affected by the loss of Tbx4 and Tbx5  
To analyze the effect of loss of Tbx4 and Tbx5 on lung branching in vivo we made use of the 
tamoxifen inducible CreER transgene.  Tamoxifen was injected at E8.75 (8-16 somites), late 
enough to bypass lethality but well before lung branching begins.  Embryos with CreER and 




 alleles were examined at E12.5 and E13.5.  
Conditional Tbx4 null lungs were similar to controls at E12.5 but had fewer branching tips at 
E13.5 (Figure 3.4A,B,E,F).  Conditional Tbx4;Tbx5 double heterozygous lungs (Figure 3.4C) 
were smaller in size and had fewer branching tips than the conditional Tbx4 null lungs at E13.5 
(Figure 3.4B) but were more advanced developmentally (Figure 3.4E,F) than the conditional 
Tbx4 null;Tbx5 heterozygous lungs (Figure 3.4D), which were severely retarded in their 
development.  Lobation in the right lung was disrupted in the conditional Tbx4 null;Tbx5 
heterozygous lungs:  the accessory lobe was missing and only rudimentary cranial and medial 
lobes were present (Figure 3.4H and Figure 3.7A,B).  The lobes had a fused appearance (Figure 
3.4H’) suggesting a failure of separation.  When these mutant lungs were sectioned and 
compared with controls, there were no obvious structural defects observed other than an overall 
reduction in size (Figure 3.4G,G’,H,H’).   
The conditional Tbx4 null;Tbx5 heterozygous mutants could not be analyzed later than 
E13.5, due to hematopoietic defects throughout the embryo because of Cre-induced apoptosis 
(Naiche and Papaioannou, 2007a) and it was not possible to analyze the conditional Tbx5 null 
embryos using the inducible CreER in vivo due to lethal heart defects. To circumvent these 
limitations, we used the Tbx4
cre 
allele, which is expressed in the lung and trachea but not in the 
heart (Luria et al., 2008).  From this allele, Cre is expressed in the majority of cells of the 
developing lung and trachea mesenchyme, as seen with a lacZ reporter expression at E13.5 





Lung-specific Tbx5 null mutants, carrying a single copy of Tbx4
cre
, showed a range of 
phenotypes from an apparently normal lung to a severe decrease in lung size.  We hypothesize 
that this variability in phenotype is due to a variable extent of recombination of the Tbx5
fl
 allele 
(Figure 3.2).  All lung-specific Tbx4 heterozygous;Tbx5 null pups became cyanotic at birth and 
died shortly thereafter due to respiratory distress.  Unlike the variable lung size in the lung-
specific Tbx5 null mutants, the lungs of these mutants were consistently smaller than the controls 
at E13.5 (Figure 3.4K,L) and at birth (Figure 3.4N,O) and had significantly fewer branching tips 
compared to controls at E13.5 (Figure 3.4M). At P0 the lung histology of the lung-specific Tbx4 
heterozygous;Tbx5 null lungs is comparable to controls although the mutant lungs and trachea 
show accumulation of a mucus like substance (Figure 3.4P,Q).  These lungs show lobation 
defects very similar to the conditional Tbx4 null;Tbx5 heterozygous mutant lungs.  The accessory 
lobe was absent in most embryos but when present showed less branching; the cranial and caudal 
lobes also showed decreased branching. The cranial, medial and caudal lobes had a fused 
appearance (Figure 3.5A,B). In addition to having fewer branches these lungs also showed 
reduction in lateral growth of the branching lung lobes. Although tertiary dorsal branches were 
present, they were crowded together and the secondary lateral branches had outgrown a shorter 
distance compared to controls (Figure 3.5C,D)  
Using Tbx4
cre
, it is not possible to study the conditional double nulls as Tbx4 is also 
expressed from this allele. Thus, to further explore branching morphogenesis in conditions where 
both alleles of Tbx4 and Tbx5 could be deleted, we made use of a lung bud culture system in 
which lung buds from embryos with or without the CreER transgene were cultured in the 
presence of 4-OH tamoxifen (Figure 3.6). Conditional Tbx4 null;Tbx5 heterozygous, or 





3.6A,B,C) consistent with the reduced number of branching tips observed in vivo at E13.5.  The 
conditional double null lungs showed a complete branching arrest by 3 days of culture (Figure 
3.6D,E,F).  The existing branches continued to elongate as seen at 4 days of culture (arrow in 
Figure 3.6E).  Therefore, Tbx4 and Tbx5 are essential for continuing branching morphogenesis ex 
vivo. 
Loss of Tbx4 and Tbx5 affects the Fgf10 signaling pathway and Wnt2 expression  
Expression of the lung mesenchymal marker Fgf10 as well as epithelial targets of the Fgf10 
signaling pathway, Bmp4, Spry2 and Etv5 (Weaver et al., 2000; Firnberg and Neubuser, 2002; 
Horowitz and Simons, 2008), was analyzed in lungs with reduced Tbx4 and Tbx5 expression.  
Fgf10 is expressed in mesenchyme surrounding the distal epithelial tips that mark the site of 
future bud formation (Figure 3.7A) (Bellusci et al., 1997).  Consistent with the smaller overall 
lung size, there were fewer foci of Fgf10 expression in the conditional Tbx4 null;Tbx5 
heterozygous lungs (Figure 3.7B) and in the lung-specific Tbx4 heterozygous;Tbx5 nulls (Figure 
3.7C).   The primary receptor for this pathway, Fgfr2 (Arman et al., 1999), is expressed normally 
in the epithelium of lung-specific Tbx4 heterozygous;Tbx5 null lungs (Figure 3.7D,E).  Bmp4 
(Figure 3.7F,G,H) and Spry2 (Figure 3.7I,J) were downregulated in the Tbx4 and Tbx5-deficient 
lungs but Etv5 (Figure 3.7N,O) expression was not affected, although it was drastically reduced 
in the conditional double nulls cultured ex vivo (see Figure 3.8J,K).  
Wnt2, which is normally expressed in the developing lung mesenchyme (Figure 3.7K) 
(Goss et al., 2009), was greatly reduced at E13.5 in conditional Tbx4 null;Tbx5 heterozygous 
(Figure 3.7L)  and lung-specific Tbx4 heterozygous;Tbx5 null lungs (Figure 3.7M). In addition to 
Fgf10 and canonical Wnt2 signaling pathways, the Shh signaling pathway has also been 





Epithelial Shh (Figure 3.7S,T) and its mesenchymal receptor Ptc (Figure 3.7U,V) showed normal 
expression in the lung-specific Tbx4 heterozygous;Tbx5 null lungs. The epithelial marker Nkx2.1 
which is necessary for lung branching (Kimura et al., 1996) and showed unilateral expression in 
the conditional Tbx5 null foreguts at the time of specification (Figure 2), showed expression 
similar to controls at E13.5 in the lung-specific Tbx4 heterozygous;Tbx5 null lungs (Figure 
3.7W,X). At E13.5, expression of the vascular marker Pecam indicated normal development of 
vessels around the individual bronchioles of the Tbx4 and Tbx5-deficient mutants (Figure 
3.7P,Q,R).   
Tbx4 and Tbx5 interact with Fgf10 during lung development 
Since mesenchymal Fgf10 expression and expression of epithelial targets was affected in 
mutants with reduced Tbx4 and Tbx5, we investigated the interactions between the Tbx4, Tbx5 
and the Fgf10 signaling pathway during branching morhphogenesis using double and triple 
heterozygotus mutants.  Tbx4;Tbx5 double heterozygous lungs were smaller than control lungs at 
E18.5 (Figure 3.8A,B).  The Tbx4;Tbx5;Fgf10 triple heterozygous lungs were smaller than the 
Tbx4;Tbx5 double heterozygous lungs (Figure 3.8B,C), suggesting that Tbx4 and Tbx5 
genetically interact with the Fgf10 signaling pathway during lung development.  Removing one 
copy of Fgf10 from the lung-specific Tbx4 heterozygous;Tbx5 nulls did not reduce lung size 
further (Figure 3.8D,E).   
Fgf10 genetically interacts with Tbx4 and Tbx5; loss of Tbx4 and Tbx5 leads to 
downregulation of Fgf10 and of genes activated downstream of the Fgf10 signaling pathway in 
the epithelium (Figure 3.7).  However, the addition of exogenous Fgf10 to lung bud cultures of 
conditional double nulls did not rescue branching (Figure 3.8F-I). The lack of change in Etv5 





presence of exogenous Fgf10 in the conditional double null lungs (Figure 3.8J-M).  To ensure 
that the Fgf10 used for the rescue experiments was active, Fgf10 coated heparin beads were 
placed near the branching tips of lung explants. The tips of both control and conditional double 
null lungs swelled up in response to Fgf10 beads but not BSA coated heparin beads (Figure 
3.8N,O) (Izvolsky et al., 2003b).  Since Fgfr2 is expressed normally in the Tbx4 and Tbx5-
deficient lungs (Figure 3.8E) and the conditional double null lungs, it is not surprising that the 
conditional double null lung tips can respond to Fgf10.  However the conditional double null 
lungs fail to undergo branching in the presence of Fgf10. Thus, in addition to Fgf10 there must 
be other factors under the control of Tbx4 and Tbx5 important for activation of the Fgf10 
signaling pathway leading to branching morphogenesis.   
Loss of Tbx4 and Tbx5 causes tracheal-bronchial ring defects 
To analyze the development of the tracheal-bronchial cartilage in embryos with reduced Tbx4 
and Tbx5, cartilage rings were visualized at birth using alcian blue staining.  The lung-specific 
Tbx5 nulls and lung-specific Tbx4 heterozygous;Tbx5 null embryos had defective cartilage ring 
development (Figure 3.9A-C).  There were some normal rings (arrows in Figure 3.9B,C) and 
isolated foci of cartilage (black arrowheads in Figure 3.9B,C).  The tracheal and bronchial lumen 
of newborn pups was expanded in the controls (Figure 3.9D,E) but collapsed in lung-specific 
Tbx4 heterozygous;Tbx5 nulls (Figure 3.9F,G).  To assess the development of cartilage rings at 
earlier stages, Sox9 expression was analyzed at E12.5 and E13.5 in lung-specific Tbx4 
heterozygous;Tbx5 nulls.  At E12.5, these mutant tracheas have Sox9 expression on the ventral 
aspect of the trachea similar to the controls (Figure 3.9H,I) but fail to undergo mesenchymal 
condensations at E13.5 (Figure 3.9J,K).  Expression of the genes downstream of Sox9, Sox6 





another Sox9 target, was expressed at apparently normal levels in those rings that were present 
(Figure 3.9P,Q).  The smooth muscle marker SM22α was analyzed to assess the development of 
the dorsal trachealis muscle.  SM22α was expressed in an expanded domain and there was a loss 
of the characteristic banding pattern in the mutant tracheas (Figure 3.9R,S) indicating a 
disruption in smooth muscle formation due to loss of Tbx4 and Tbx5.   
Tbx4 and Tbx5 do not interact with Fgf10 during trachea development 
Tracheas of controls (Figure 3.10A), Tbx4;Fgf10 double heterozygotes (Figure 3.10B) and 
Tbx5;Fgf10 double heterozygotes (Figure 3.10C) showed a normal pattern of 10-11 cartilage 
rings, suggesting a lack of genetic interactions between Tbx4 or Tbx5 and Fgf10 in trachea 
formation.  Fgf10 null mutants do not form lungs but have a truncated trachea with 6-8 cartilage 
rings, some of which are aberrantly formed (Sala et al., 2011) (Figure 3.10D).  Tbx4;Tbx5 double 
heterozygous mice also have tracheas with 6-8 cartilage rings but also have main stem bronchial 
cartilage rings (Figure 3.10E).  Removing a copy of Fgf10 in these double heterozygotes did not 
alter the phenotype (Figure 3.10F) showing an Fgf10-independent role for Tbx4 and Tbx5 in the 
formation of tracheal-bronchial cartilage rings.  Also, removing a copy of Fgf10 in the lung-
specific Tbx4 heterozygous;Tbx5 nulls did not alter the phenotype of the tracheal-bronchial 
cartilage rings (Figure 3.10G,H).  Thus, Tbx4 and Tbx5 affect lung development via control of 
Fgf10 expression but affect tracheal-bronchial cartilage development independently of the Fgf10 
signaling pathway. 
Discussion 
Loss of Tbx5 affects specification of the lung buds and trachea 
Tbx5 is expressed around the lung/trachea primordia at the same time that Nkx2.1, a marker of 





slightly later at the time of lung bud formation.  In our study, loss of Tbx5, but not Tbx4, leads to 
unilateral loss of lung bud formation, indicating that Tbx5 is important for lung bud specification.  
In contrast, in the chick, although ectopic expression of Tbx4 in the esophagus can specify lung 
fate,  expression of a dominant negative form of Tbx4 leads to a lack of primary budding in only 
a third of the mutants analyzed  (Sakiyama et al., 2003). However, the dominant negative Tbx4 
could also be affecting the expression of Tbx5 targets as the repressor construct utilized the 
complete T-box domain and Tbx4 and Tbx5 have 94% amino acid identity in their T-box 
domains (Epstein et al., 2008).  This interpretation is compatible with our hypothesis that Tbx5 
plays a more important role in vertebrate lung primordia specification than Tbx4 (Figure 3.11A).  
Loss of Tbx5 alone leads to a lack of tracheal specification ex vivo, a phenotype similar to 
that of mice mutant for Bmpr1 and Bmpr2.  In these mutants, although lung bud specification 
occurs, the ventral foregut fails to acquire tracheal identity (Domyan et al., 2011).  Thus, Tbx5 
either acts upstream of or in parallel with the BMP signaling pathway in specification of the 
foregut into a trachea (Figure 3.11A).   
Tbx4 and Tbx5 interactions in lung development 
At the next stage of lung development, in lung branching morphogenesis, Tbx4 and Tbx5 
genetically interact with one another.  Although, neither Tbx5 nor Tbx4 single heterozygous 
lungs show a branching defect, double heterozygous lungs are smaller at E13.5 and E18.5 with a 
reduced number of branching tips at E13.5. Because these genes are closely related (Epstein et 
al., 2008), they could potentially activate the same targets by binding to a similar T-box binding 
element, independent of one another. Alternatively, Tbx4 and Tbx5 could physically interact with 
each other as heterodimers to activate and/or repress transcription of downstream targets, as has 





Further reduction of Tbx4 or Tbx5 in conditional Tbx4 nulls;Tbx5 heterozygous and lung-
specific Tbx4 heterozygous;Tbx5 null lungs leads to a severe reduction in branching, failure of 
lobe separation and loss of lung lobe specification, while absence of Tbx4 and Tbx5 leads to a 
branching arrest. These results are in line with the published observations that antisense RNAs 
used against both Tbx4 and Tbx5 inhibit lung branching in culture and that this effect is 
explained by loss of Fgf10 expression (Cebra-Thomas et al., 2003).  The drastic effect on lung 
branching in our study is explained by loss of expression of the important regulatory genes Fgf10 
and Wnt2 in the lung mesenchyme.  The Fgf10 targets Bmp4 and Spry2 show very low levels of 
expression in the epithelium of Tbx4 and Tbx5-deficient mutants and Etv5, another Fgf10 target, 
shows greatly reduced expression in the conditional double null lungs, leading to the hypothesis 
that the Fgf10 signaling pathway is activated downstream of Tbx4 and Tbx5 in the developing 
lung and that Fgf10 genetically interacts with Tbx4 and Tbx5. Lungs that are triple heterozygous 
for Tbx4, Tbx5 and Fgf10 are reduced in size compared to Tbx4;Tbx5 double heterozygous lungs, 
which supports this hypothesis. Lung-specific Tbx4 heterozygote;Tbx5 null lungs are severely 
retarded but lung size is not affected by further loss of Fgf10, demonstrating epistasis and 
supporting the hypothesis that Fgf10 lies downstream of Tbx4 and Tbx5.  Lack of rescue of 
branch formation and lack of activation of the Fgf10 signaling pathway by exogenously supplied 
Fgf10 in culture suggests that there are other factors downstream of Tbx4 and Tbx5 that affect 
Fgf10 signaling.  Although, lungs deficient in Tbx4 and Tbx5 retain the ability to respond to 
Fgf10 coated beads (our study and (Cebra-Thomas et al., 2003)), they fail to activate additional 
factors necessary for branching morphogenesis (Figure 3.11B). 
One possibility for such a factor is a mesenchymal signaling molecule that communicates 





pathway.  We examined expression of Ptc and Shh to determine whether the Shh pathway was 
involved, but Shh signaling is not affected in the lung-specific Tbx4 heterozygous;Tbx5 nulls or 
in the conditional double null cultures.  The extracellular matrix (ECM) molecules, heparan 
sulfate (HS) proteoglycans aid in Fgf10-Fgfr2 interactions during lung development (Izvolsky et 
al., 2003b) and hence are good candidates for factors  missing in the Tbx4 and Tbx5-deficient 
mutants.  Inhibition of heparanase decreases submandibular gland morphogenesis in culture due 
to deficiency of Fgf signaling (Patel et al., 2007).  Additionaly, HS-deficient null mouse embryos 
fail to respond to Fgf signaling and the spatiotemporal expression of cell surface-tethered HS 
chains regulates the local reception of Fgf-signaling activity during embryonic development 
(Shimokawa et al., 2011).  Tbx4 regulates ECM molecules in the developing allantois, 
specifically the chondroitin sulfate proteoglycan versican (Fig. 2.2), suggesting that ECM might 
be one of the targets for T-box genes in regulating development of other organs as well.   
Tbx4 and Tbx5 interactions in tracheal-bronchial cartilage development 
Appropriate dorsal smooth muscle development and ventral tracheal-bronchial cartilage 
development is important for the normal functioning of the trachea.  Smooth muscle provides 
tracheal flexibility and the cartilaginous rings prevent tracheal collapse.  Defects in trachea 
formation may result in tracheomalacia or tracheal stenosis.  Reduction of Tbx4 and Tbx5 causes 
defects in both formation of the tracheal cartilage rings and development of the trachealis smooth 
muscle indicating interactions between Tbx4 and Tbx5.  Tbx4 heterozygous and Tbx5 
heterozygous tracheas have 10-11 cartilage rings but Tbx4;Tbx5 double heterozygous tracheas 
have 6-8 cartilage rings, some of which are incomplete. Additional reduction of Tbx4 and Tbx5 





cartilage ring formation further supporting genetic interactions between Tbx4 and Tbx5 in trachea 
formation.  
Sox9, a master regulator of the process of chondrogenesis is expressed normally at E12.5 
throughout the ventral mesenchyme in lung-specific Tbx4 heterozygous;Tbx5 null tracheas but at 
E13.5 these tracheas show a lack of characteristic mesenchymal condensations and reduced Sox9 
expression.   Either Tbx4 and Tbx5 control of Sox9 expression becomes more sensitive to dosage 
at E13.5 or Tbx4 and Tbx5 control another factor, possibly an ECM molecule, which is important 
for formation of mesenchymal condensations and, in the absence of these condensations, there is 
a down regulation of Sox9 expression (Figure 3.11C).  Expression of Sox5 and Sox6, genes 
genetically downstream of Sox9 and important for condensation and cartilage formation, is 
downregulated at E13.5, concordant with an aberration in the process of chondrogenesis.  
While Tbx4 and Tbx5 regulate lung branching by controlling Fgf10 signaling, their 
control of tracheal-bronchial cartilage formation is independent of the Fgf10 signaling pathway.  
Fgf10 homozygous mutants have 6-8 tracheal cartilage rings, although the spacing between them 
is reduced and the rings do not always form the characteristic C shape (Min et al., 1998; Sekine 
et al., 1999; Sala et al., 2011).  Neither Tbx4;Fgf10 double heterozygous tracheas nor 
Tbx5;Fgf10 double heterozygous tracheas show cartilage condensation defects or a reduction in 
the number of cartilage rings present. In contrast, Tbx4;Tbx5 double heterozygotes show a 
shorter trachea with 6-8 tracheal cartilage rings suggesting Tbx4 and Tbx5 interact with each 
other during trachea formation but do not interact with Fgf10. The triple heterozygous tracheas 
do not show an exacerbation of the Tbx4;Tbx5 double heterozygous trachea phenotype. 
Additionally, aberrant Fgf10 signaling has been shown to affect tracheal cartilage formation and 





the Tbx4 and Tbx5-deficient mutants Shh expression appears to be unaffected whereas Sox9 
expression is reduced at E13.5.  Hence, Tbx4 and Tbx5 control tracheal-bronchial cartilage 









Figure 3.1 Expression of Tbx4 and Tbx5 in the developing lung and trachea.  (A-J) Tbx4 and 
Tbx5 expression analyzed using ISH on lungs.  Tbx5 is first expressed at E9.0 (B) when the 
specification of lung primordia occurs, as seen by Nkx2.1 expression (A).  Tbx4 is first expressed 
at E9.5 along with Tbx5 in the newly formed lung buds (C,D).  Expression is seen in lung whole 
mounts at E11.5 (E,F), E13.5 (G,H) and in lung mesenchyme in cryosections at E15.5 (I,J). (K-
Q) Tbx4 and Tbx5 expression analyzed using ISH on tracheas. Tbx4 and Tbx5 are expressed 
throughout tracheal mesenchyme (m) at E13.5 (K,K’,L,L’) but not in the epithelium (e) or the 
mesothelium (arrowheads). Caudal view of cut tracheas after whole mount ISH (K-N).  ISH on 





(M,M’) and SM22α is expressed on the dorsal side (N,N’) of the trachea. D-dorsal; V-ventral; R-
right; L-left.  At E15.5, Tbx4 and Tbx5 are expressed around the condensing cartilage 
mesenchyme and in the intercartilage mesenchyme (O,P).  Sox9 is expressed in the condensing 
cartilage rings (Q). Asterisk indicates areas of cartilage condensation.  Inset in (O) and (Q) 
shows ISH on E15.5 sagittal cryosections with Tbx4 and Sox9 probe respectively.  Scale bars 

















 and CreER alleles were injected with either 8mg tamoxifen at E9.0 and 
dissected at E12.5 (A,E) or 7mg tamoxifen at E8.5 and dissected at E13.5 (B,F).  Tbx4
fl/fl
 was 
completely excised to mutant Tbx4
-/-
 at both doses and times (A,B) whereas the single 
conditional allele of Tbx5
fl/+
 was incompletely excised by injection at E9.0 (E) but completely 





CreER were treated with 1µm tamoxifen in culture, the Tbx4 locus was nearly completely 
excised at the end of 1 day of culture (C) but the Tbx5 locus was only partially excised (G). At 
the end of a 4 day culture both Tbx4 (D) and Tbx5 (H) loci achieved virtually complete excision.  








Figure 3.3 Early loss of Tbx5 leads to aberrant lung bud and trachea specification. (A-I) 
Foreguts were isolated between 8-16 somite stages and analyzed by ISH following culture.  
Nkx2.1 (A), Tbx4 (B) and Tbx5 (C) expression in lung buds (arrows) and tracheal primordia 
(yellow arrowhead) was confirmed in control cultures.  Recombination of Tbx5 using 4-OH 
tamoxifen in conditional null foreguts with CreER leads to the loss of Nkx2.1 expression in one 
of the lung buds at 3 (E) or 4 days (H).  Conditional double nulls (F,I) carrying  CreER show a 
phenotype similar to the conditional Tbx5 nulls, suggesting additional removal of Tbx4 does not 
exacerbate the phenotype. Nkx2.1 expression was absent in the foregut tube of conditional Tbx5 
null and conditional double null foreguts after 3 or 4 days of culture (yellow arrowheads in 








Figure 3.4 Loss of Tbx4 and Tbx5 causes reduced lung branching and lethality at birth.   
(A-H’) Tbx4fl and Tbx5fl alleles were excised using CreER by injecting tamoxifen at E8.75 and 
lungs were dissected at different time points.  Loss of Tbx4 alone or both Tbx4 and Tbx5 leads to 
lung hypoplasia at E13.5 (A-D).  The number of branching tips was quantitated following E-
cadherin staining for different genotypes at E12.5 (E) and E13.5 (F).  H & E on histological 





lungs (G,H,). (G’) and (H’) are magnified views of the boxed regions in (G) and (H) 
respectively.  Black arrowheads indicate separation between the lobes of the right lung in the 
control (G’) and lack of separation in the mutants (H’). (I-Q) Tbx4cre was utilized for lung and 




 alleles.  Tbx4
cre
 was expressed in most of the 
trachea mesenchyme (I) and lung mesenchymal cells (J) as seen by a R26RlacZ reporter 
expression at E13.5.  Lung-specific Tbx4 heterozygous;Tbx5 null lungs show hypoplasia at 
E13.5 (K,L) and at birth (N,O).  The number of branching tips in control lungs and the lung-
specific Tbx4 heterozygous;Tbx5 null lungs, labeled as experimental in the box plot (M), are 
significantly different at E13.5.  H & E staining on sections shows lung morphology for control 








Figure 3.5 Loss of Tbx4 and Tbx5 has multiple affects on branching morphogenesis.  (A,B) 
H & E sections of lung specific Tbx4 heterozygous;Tbx5 null lungs (B) show lack of separation 
of the cranial (cr), medial (m) and caudal (cd) lobes in the right lung as compared to control 
lungs (A). Black arrowheads point to the space between the lobes in the control lungs (A) and to 
the corresponding regions of the mutant lungs (B).  (C,D) Control lungs stained for E-cadherin 
at E13 show greater outgrowth (yellow brackets) of lateral branches (C) than the lung specific 







Figure 3.6 Loss of Tbx4 and Tbx5 leads to branching arrest ex vivo.  Lung buds were isolated 
at E11.5 and cultured in the presence of 4-OH tamoxifen. Airways were visualized using E-
cadherin ISH. Conditional Tbx4 homozygous;Tbx5 heterozygous (B) and conditional Tbx4 
heterozygous;Tbx5 null (C) lungs with CreER showed reduced branching after 4 days of culture 
compared to controls (A). Control, without CreER, (D) and conditional double null lung buds, 
with CreER, (E) were cultured for 4 days and photographed at 1 day, 2 days, 3 days and 4 days.  
Arrow in E shows the progression of an elongating airway.  A plot of the number of branching 
tips as a function of time for controls and the conditional double nulls (F), shows a branching 







Figure 3.7 Loss of Tbx4 and Tbx5 affects the Fgf10 signaling pathway and Wnt2 expression. 
(A-X) Marker analysis of control and Tbx4 and Tbx5-deficient lungs using whole mount ISH (A-
O, S-X) and IHC (P-R): Fewer foci of Fgf10 expression were seen in the Tbx4 and Tbx5-
deficient lungs (B,C)  compared to control (A). cr, cranial; m, medial; cd, caudal; a, accesory 
lobes. Fgf10 target genes Bmp4 (F,G,H) and Spry2 (I,J)  and canonical Wnt2 (K,L,M) were 
downregulated in Tbx4 and Tbx5-deficient lungs compared to controls. Fgfr2 (D,E), Etv5 (N,O), 
Pecam (P,Q,R), Shh (S,T), Ptc (U,V) and Nkx2.1 (W,X) were expressed similarly in controls and 









Figure 3.8 Tbx4 and Tbx5 interact with Fgf10 but FGF10 fails to rescue Tbx4 and Tbx5-
deficient lungs. (A-E) Lungs of different genotypes at E18.5. Tbx4;Tbx5 double heterozygous 
lungs (B) are smaller than control lungs (A). Tbx4;Tbx5;Fgf10 triple heterozygous lungs (C) are 
smaller than the double heterozygous lungs (B) but comparable in size to the lung-specific Tbx4 
heterozyous;Tbx5 null lungs (D). Removing an additional copy of Fgf10 from the lung-specific 
Tbx4 heterozyous;Tbx5 null lungs does not further affect lung size (E). ht, heart. (F-I) E-cad 
expression in epithelium of the control lungs and conditional double null lungs in the absence 
(F,G) and presence (H,I) of exogeneous Fgf10 showing a lack of rescue of branching 
morphogenesis.   (J-M) Etv5 expression in control lungs and conditional double null lungs in the 
absence (J,K) and presence (L,M) of exogeneous Fgf10. Etv5 expression remains unchanged 
after addition of Fgf10. (N,O) Both control and conditional double null lungs respond to FGF10 
coated beads (f) but not to BSA coated beads (b) as seen by swelling of tips (arrows) in 







Figure 3.9 Loss of Tbx4 and Tbx5 disrupts tracheal-bronchial cartilage and smooth muscle 
formation. (A-G) Alcian blue staining was used to visualize tracheal-bronchial cartilage.  Ten-
eleven cartilage rings were seen in control tracheas (E18.5, A); normal (arrow) and incomplete 
rings were seen in tracheas and bronchi (black and red arrowheads respectively) of lung-specific 
Tbx5 null (E18.5, B) and lung-specific Tbx4 heterozygous;Tbx5 nulls  (post natal day (P)0, C). 
Asterisk in (A-C) is the point of bronchial separation from the trachea. Alcian blue on P0 
sections showed that the control trachea (D) and main stem bronchial lumen (E) were expanded 
and the chondrocytes were present as C shaped rings (arrowheads).  The lung-specific Tbx4 
heterozygous;Tbx5 null tracheal lumen (F) and main stem bronchial lumen (G) were collapsed 
and filled with a mucus like substance (arrows) and alcian blue positive foci were seen 
(arrowheads). TL, Tracheal lumen; RBL, Right bronchial lumen; LBL, Left bronchial lumen.  
(H-S) Genes important for chondrogenesis and smooth muscle development. Sox9 expression at 
E12.5 showed a comparable ventral expression pattern in control (H) and lung-specific Tbx4 
heterozygous;Tbx5 null tracheas (I). At E13.5, Sox9 positive cells begin to condense and appear 
in a ring like pattern in controls (J) but not in the mutant tracheas (K).  Sox6 (L,M) and Sox5 
(N,O) expression was downregulated in the lung-specific Tbx4 heterozygous;Tbx5 null tracheas 
at E13.5. Col21 was expressed in its characteristic ring like pattern (P) similar to Sox9 in the 





specific Tbx4 heterozygous;Tbx5 null tracheas (Q). SM22α expression was analyzed on the 
dorsal trachea at E13.5 in the control (R) and in the lung-specific Tbx4 heterozygous;Tbx5 null 
tracheas (S).  Arrowheads in (S) point to ectopic expression in an uncharacteristic pattern in the 








Figure 3.10 Lack of genetic interactions between Tbx4, Tbx5 and Fgf10 in trachea 
formation.  Alcian blue staining was used to analyze tracheal-bronchial cartilage development in 
tracheas from different genotypes at E18.5. Control tracheas (A), Tbx4;Fgf10 double 
heterozygous tracheas (B) and Tbx5;Fgf10 double heterozygous tracheas (C) have 10-11 C-
shaped, ventral tracheal cartilage rings and the trachea forms the two main stem bronchi which 
have lateral C-shaped cartilage rings.  Fgf10 homozygous mutants (D), Tbx4;Tbx5 double 
heterozygous mutants (E) and Tbx4;Tbx5;Fgf10 triple heterozygous mutants (F) each form fewer 
(6-8) tracheal cartilage rings, some irregularly shaped or incomplete (arrowheads). Additionally, 
Fgf10 mutants lack bronchi and hence any bronchial cartilage rings, but the double and triple 
heterozygotes form normal lateral bronchial cartilage rings (arrows in E and F). Lung-specific 
Tbx4 heterozygous;Tbx5 nulls (G) show severe disruptions in formation of tracheal-bronchial 
cartilage rings, a phenotype that  is unchanged with the removal of an Fgf10 allele (H). Asterisk 








Figure 3.11 Model for the role of Tbx4 and Tbx5 in lung and trachea development. (A) Lung 
and trachea specification begins at E9.0 in the ventral foregut and at this time Tbx5 expression 
(light purple) is adjacent to the presumptive endoderm. Later, Tbx4 and Tbx5 expression (dark 
purple)  is in mesenchyme associated with the lung and trachea. Tbx5 but not Tbx4 is important 
for specification of bilateral lung buds and the trachea. (B) Magnification of box shown in (A) 
representing the events in the growing tip during branching morphogenesis. Grey denotes 
epithelium and purple denotes mesenchyme. Tbx4 and Tbx5 interact with each other and act 
upstream of the Fgf10 signaling pathway. Decrease in Tbx4 and Tbx5 affects mesenchymal 
Fgf10 expression and expression of its targets in the epithelium – Bmp4, Spry2 and Etv5 – but 
not the expression of the epithelial Fgf10 receptor Fgfr2. In addition to Fgf10 expression in the 
mesenchyme, Tbx4 and Tbx5 also control the expression of an unknown factor (X) that is 
essential for activation of the Fgf10 signaling pathway. Furthermore, Tbx4 and Tbx5 act 
upstream of Wnt2 in the mesenchyme. (C) In the trachea and the main stem bronchi Tbx4 and 
Tbx5 either control Sox9 expression, which in turn regulates cartilage condensation, or Tbx4 and 
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Chapter 4. T-box gene function in organogenesis 
 
Our studies on the allantois and the respiratory system suggest common themes for T-box 
function.  
T-box genes lie upstream of Fgf signaling 
T-box genes have been implicated upstream of Fgf signaling in different organs.  Fgf8 interacts 
genetically with Tbx1 during pharyngeal endoderm, mesoderm and aortic arch development 
(Vitelli et al., 2002b; Mesbah et al., 2012).  Fgf8 expression is upregulated in the secondary heart 




 double mutants suggesting that these T-box genes 
repress Fgf8 expression during heart development (Mesbah et al., 2012).  In Tbx4 mutant 
hindlimbs Fgf10 expression is initiated but not maintained (Naiche and Papaioannou, 2003).  In 
Tbx5 mutant forelimbs expression of Fgf8, Fgf10 and a downstream target of Fgf10 signaling, 
Pea3, is not present at initiation (Agarwal et al., 2003) nor during later outgrowth (Rallis et al., 
2003).  A similar role for Tbx5 upstream of Fgf10 has been suggested in pectoral fin 
development in zebrafish (Ng et al., 2002) and in limb development in the chick (Takeuchi et al., 
2003).  Further the Fgf10 promoter has a conserved T-box binding site which can be activated in 
vitro by TBX5 protein (Agarwal et al., 2003).  This suggests that Fgf10 is a direct target of Tbx5 
and potentially of Tbx4 since both these proteins have a highly homologous T-box amino acid 
domain.  In the chick lung bud ectopic expression of Tbx4 leads to ectopic expression of Fgf10 
and expression of a dominant negative construct of Tbx4 leads to reduced Fgf10 expression in 
the lung bud mesenchyme (Sakiyama et al., 2003).  Further, when lung bud cultures are treated 
with both Tbx4 and Tbx5 antisense RNA, Fgf10 expression is reduced in the branching lung 





genes, where upon reduction in both Tbx4 and Tbx5, Fgf10 expression in the mesenchyme and 
Fgf10 target expression in the epithelium – Bmp4 and Spry2 is greatly reduced.  We also see that 
Tbx4, Tbx5 and Fgf10 interact in lung branching morphogenesis by means of triple heterozygous 
mutants.  In contrast, it is important to note that although regulation of Fgf10 expression by T-
box genes is a common theme, this does not happen in all developing organs.  In the developing 
trachea Fgf10 does not interact with Tbx4 or Tbx5 although aberrant Fgf10 expression by itself 
affects tracheal cartilage formation. 
T-box genes interact with canonical Wnt signaling 
Another signaling pathway that lies downstream of T-box genes or interacts with them is the 
canonical Wnt signaling pathway.  In zebrafish, both brachyury homologs no tail and brachyury 
are essential and sufficient for expression of canonical wnt3a and wnt8 in the mesoderm 
progenitors for formation of the posterior somites (Martin and Kimelman, 2008).  In the mouse 
embryo T and Tbx6 interact with canonical wnt signaling to activate notch signaling in the 
presomitic mesoderm (Hofmann et al., 2004).  Tbx16 or spadetail regulates the canonical Wnt 
signaling pathway in the intermediate mesoderm of the developing zebrafish, which is also the 
site of primitive red blood cell formation (Mueller et al., 2010).  In Tbx5 mutant forelimb limb 
buds Lef1, Tcf1 and Snai1, all targets of canonical Wnt signaling, are absent suggesting that Tbx5 
lies upstream of canonical Wnt signaling during forelimb bud growth (Agarwal et al., 2003).  In 
zebrafish tbx5 and wnt2b interact to initiate and specify forelimb identity (Ng et al., 2002).  We 
show that Tbx4 lies upstream of Wnt2, and four genes suggested to be direct downstream targets 
of canonical Wnt signaling – Snai1, Twist, Versican and Jagged1– in the developing allantois.  
Further, both Tbx4 and Wnt2 interact in allantois-derived vascular network formation in the 





lung suggest that Tbx4 and Tbx5 regulate Wnt2 expression during lung branching 
morphogenesis.   
T-box genes regulate expression of major components of extracellular matrix 
Finally our work suggests a role for Tbx4 and Tbx5 in the regulation of extracellular matrix 
during organ formation.  There have been multiple studies linking T-box gene function to matrix 
regulation indicating that this might be a common theme through which Tbx genes act in 
different tissues.  Decrease in expression of eight Tbx genes Tbx1, Tbx2, Tbx3, Tbx4, Tbx5, 
Tbx15, Tbx18, Tbx21 during hind limb chondrogenesis was observed when comparing 
expression in E11.5 anlagen, E12.5 condensations and E13.5 cartilage anlagen (Cameron et al., 
2009).  This decrease in expression suggests that T-box genes are expressed in mesenchyme that 
has chondrogenic potential but not in cells that are actively undergoing condensation.  These 
results are similar to the results we obtained in the tracheal cartilage, where Tbx4 and Tbx5 are 
expressed in the chondrogenic mesenchyme at E11.5 but not expressed in mesenchymal 
condensations and the cartilage anlagen at E15.5.  In primary avian endocardial cells, Tbx20 
overexpression leads to repression of chondroitin sulphate proteoglycans Aggrecan and 
Versican, and increased expression of Mmp9 and Mmp13.  Further, Tbx20 plays a role in 
repression of extracellular matrix remodeling and activation of mesenchymal proliferation 
(Shelton and Yutzey, 2007). In zebrafish the T-box gene spadetail, regulates the transcription of 
cell adhesion molecule paraxial protocadherin in the trunk mesoderm during morphogenesis 
(Yamamoto et al., 1998).  Over-expression of Tbx2 in human embryonic kidney cells also 
upregulates three genes involved in extracellular matrix formation and remodeling – Mmp2, Ctgf 
and Acta2 (Butz et al., 2004).  In another study over-expression of Tbx2 in NIH3T3 cells leads to 





type Iα and downregulation of Cadherin 3 and Tenascin C (Chen et al., 2001) further 
highlighting the transcriptional regulation of extracellular matrix components by the T-box 
genes.  Our work highlights different extracellular matrix genes Has2, Vcan and Itgα5 regulated 
by Tbx4 in the developing allantois.  Amongst these genes both Has2 and Vcan are implicated in 
the process of cavitation which is important for the maturation of the developing allantois.  In the 
branching lung, inability of Fgf10 to rescue the Tbx4 and Tbx5 mutant phenotype suggests that 
these T-box genes regulate additional matrix molecules that aid in Fgf10-Fgfr2 interactions.  
Finally, Tbx4 and Tbx5 deficient tracheas show defective cartilage condensations, although Sox9 
a master regulator for cartilage formation is initially expressed normally in these tracheas.  This 
further suggests a role for Tbx4 and Tbx5 in regulating appropriate ECM to support 
mesenchymal condensations and cartilage ring formation. 
Future perspectives 
The research described in this thesis addresses the role of Tbx4 in allantois development and 
proposes different functions for Tbx4 and Tbx5 in the development of the respiratory system.  
However, there are still many unanswered questions and possible hypotheses to explore, some of 
which are described below: 
i) Our studies describe Tbx4 as a master regulator of allantois vascular development.  This study 
raises the question, if there is a general role of T-box genes in vasculogenesis?  Although Tbx2 
and Tbx3 are expressed in the allantois, null mutations in neither of these T-box genes produce 
an allantois vascular phenotype.  On the other hand, Tbx20 null mutant embryos show defects in 
the development of yolk sac vasculature and Tbx3 has been implicated in development of the 





is that different T-box genes could potentially regulate a similar sub-set of genes important for 
vascular development and this hypothesis should be tested further. 
ii) Tbx4 mutant allantoises provide for a good tool for studying the process of endothelial cell 
tube formation using the adherent allantois cultures.  As used to study the canonical Wnt 
signaling pathway, these mutant allantois cultures could be used to screen small molecule 
agonists and antagonists of different pathways for a rescue of Tbx4 mutant phenotype to discover 
additional molecules that affect endothelial cell assembly. 
iii) We show that Tbx4 and Tbx5 interact during the development of the respiratory system, but 
whether they have overlapping functions or distinct functions is unclear.  Tbx5 is expressed 
before Tbx4 in the lung/trachea primordia and loss of Tbx5 but not Tbx4 at this early time leads 
to aberrant specification pointing to a role for Tbx5 during specification independent of Tbx4 
function.  On the other hand, increasing the number of Tbx4 and Tbx5 null alleles leads to an 
increase in the severity of the lung branching morphogenesis and tracheal cartilage phenotype, 
suggesting interactions.  Whether these interactions are due to additive, overlapping or distinct 
functions is unclear.  This is also the first study where the interactions and functions of Tbx4 and 
Tbx5 are studied in a tissue where these genes are co-expressed.  This hints at possible redundant 
and discreet functions of these genes in other tissues where they are co-expressed, for example 
the genital tubercle. 
iv) Sox9 is considered to be the master transcriptional regulator of cartilage formation.  In our 
Tbx4 and Tbx5-deficient mutants, Sox9 is expressed normally to begin with, but cartilage fails to 
form.  These data indicate that there are unknown regulators of chondrogenesis downstream of 
Tbx4 and Tbx5, in the absence of which, Sox9 is insufficient to induce mesenchymal 





v) The smooth muscle expansion defect in the Tbx4 and Tbx5-deficient mutants could be 
secondary to cartilage defect, as has been seen for other mutants. Alternatively, since the two 
ectopic stripes of smooth muscle expression in the mutants are very close in position to the two 
vagus nerves that run across the length of the trachea, the ectopic smooth muscle expression 
could be in these nerves. This can be addressed by staining for markers of nerve differentiation 
and SM22α and analyzing colocalization.  This analysis would shed light on the normal 
differentiation pathway of the airway smooth muscle and the nerve components of the trachea 
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